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Abstract 
 
Accessing Fused and Spirocyclic Ring Formations via Carbon – Carbon 
Bond Activation 
 
Nikolas Alexander Savage, M.A. 
The University of Texas at Austin, 2013 
 
Supervisor:  Guangbin Dong 
 
Carbon-carbon bonds are ubiquitous in synthetic chemistry and constitute the 
skeletal backbone of a significant number of compounds. Utilizing transition metal 
mediated catalysis, a wide array of fused and spirocyclic ring systems containing diverse 
functionalization were accessed.  These investigations provide unique ways to prepare 
carbon frameworks that are otherwise nontrivial to construct using classical approaches. 
The derivatives were rapidly accessed through optimized methods. 
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Chapter 1: Carbon – Carbon Bond Activation 
1.1 Introduction 
 
In an attempt to discover ideal chemical syntheses, many efforts have focused on 
the direct functionalization of carbon – hydrogen (C–H) bonds present on existing 
molecular core structures.1 However, the construction of these intricate, carbon-based 
backbones oftentimes lacks efficient or generally applicable synthetic methods. Bridged 
and fused ring systems, in particular, are prevalent in a variety of natural products (e.g. 
terpenes and alkaloids, and the selected examples shown in Figure 1.1) and exhibit a 
variety of potent biological activities.2,3  
 
Figure 1.1 Complex Natural Product Targets. 
 
The production of these rigid structures often relies upon cycloadditions or 
stepwise ring constructions that, although well studied, are fundamentally limited by their 
lengthy syntheses, specificity of reacting groups involved, and limited number of 
concurrent bond formations.4,5,6 As efficiency in synthesis is a significant venture toward 
advancing the field of chemistry, it is of paramount importance to develop atom-
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economical and selective synthetic techniques based upon carbon – carbon (C–C) bond 
activation of relatively inert C–C bonds and transform them into their reactive metal-
carbon analogues. A method toward building complex ring systems that stems from a 
reliable feedstock of cheap, readily available starting materials and overcomes previous 
synthetic limitations is uniquely challenging and thus of principal importance, as outlined 
below (Figure 1.2). Herein, the use of cyclic ketones as reaction precursors is proposed, 
which in the presence of transition metal catalysts can be preferentially “cut” open, and 
following migratory insertion of a pendant olefin, can be “sewn” together upon reductive 
elimination to afford a diverse array of new cyclized products.  
Figure 1.2 A Unified Approach to Fused Ring Systems.  
 
Prior literature lends credence to the proposed research. In 1984, Liebeskind and 
coworkers reported the use of a stoichiometric cobalt complex to cyclize a 
benzocyclobutendione and a tethered alkyne.7 Later, in 2002, Ito and Murakami 
illustrated the catalytic intramolecular insertion of styrene-type olefins into 
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cyclobutanones to afford bridged bicycles, discovering that the substrate scope was 
limited to mono-substituted aryl olefins (Figure 1.3).8  
 
 
 
 
 
 
 
Figure 1.3 Selected Examples of Ring Formation. 
 
These seminal discoveries exhibited the formation of bridged-ring systems via C–
C activation, but they did not further explore the scope of this reactivity. Herein, we 
report the investigation of new catalytic systems toward accessing fused and spirocyclic 
carbon-based ring systems.  The research presented involves the synthesis and 
characterization of a wide variety of substrates that afford cyclized products dependent 
upon reaction conditions. The effects of both steric size and electronic substitution on 
catalysts, ligands, reaction additives and substrates were studied in order to discover 
unique modes of reactivity. With a wide array of synthetic products, further 
transformations were also undertaken.   
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Chapter 2: Efficient Synthesis of Chiral Poly-Fused Rings 
(With Dr. Tao Xu and Dr. Haye Min Ko) 
2.1 Introduction 
 
Catalytic asymmetric transformations via C–C activation are significantly less 
studied than their C–H counterparts. Asymmetric metal-catalyzed C–C cleavage has 
mainly been achieved via β-carbon elimination of tert-cyclobutanolates generated in situ 
from cyclobutanolates or via deprotonation of corresponding tert-cyclobutanols.9,10,11,12 
Although elegant, this small sample of work suggests that metal-mediated 
transformations are considerably underdeveloped.  In particular, the work reported 
recently by Murakami and coworkers is the only known example of catalytic 
enantioselective carboacylation of olefins (Scheme 2.1).13  
 
 
 
 
 
Scheme 2.1 Catalytic Enantioselective Acylation of Olefins, Murakami. 
 
In their work, Murakami illustrates the nickel-mediated cyclometallation into the 
cyclobutanone C–C bond, which upon β-carbon elimination affords bridged-ring 
products. In this vein, we were interested in an effective method to access chiral fused 
ring systems. Based upon our recent discovery of an intramolecular olefin carboacylation 
with benzocyclobutanones that afforded racemic products utilizing dppb as a ligand, we 
investigated an enantioselective variant of this transformation.14 
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2.2 Research Objectives 
 
In this chapter, an enantioselective rhodium-catalyzed carboacylation via a metal-
insertion into benzocyclobutenone C–C bonds to access tricyclic fused rings is 
highlighted. These ring systems can then be further manipulated through a catalytic 
reductive dearomatization to afford fully saturated cyclic products. The success of this 
transformation, however, must first address two distinct challenges. The first is general; a 
larger energy difference is needed between the diastereomeric transition states at high 
temperatures to achieve the same level of enantioselectivity (i.e. to obtain 95% ee, ΔG‡ = 
12.3 kJ/mol is needed at 130 oC versus ΔG‡ = 9.1 kJ/mol at r.t.). The second derives from 
the sensitivity of this rhodium-catalyzed reaction to the ligand employed, where 
discovering conditions that afford both high enantioselectivities and reactivities is 
nontrivial.14 The compounds investigated were chosen for the purpose of elucidating the 
steric and electronic tolerance of the reaction conditions.  
 
2.3 Results and Discussion 
 
 The synthesis of C–C activation substrates stemmed from a [2+2] coupling of 
derivatized benzynes and ketene acetals as detailed in later supplemental information. For 
early optimization studies, substrate 2.1a was used as the model substrate. A series of 
rhodium-I pre-catalysts were investigated; it was ultimately determined that [Rh(cod)Cl]2 
was the optimal system (entries 1-4, Table 2.1). Based on our previous results that 
suggested the importance of bidentate ligands with wide bite angles to successfully 
enable this transformation, chiral bidentate phosphine ligands containing a four carbon 
linkage were firstly examined. Although BINAP and Tol-BINAP provided low yields and 
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enantioselectivites (entries 7 and 8), switching to DIOP provided both a good yield (73%) 
and ee (83%). Attempts to further enhance the enantioselectivites with bulkier DIOP 
ligands, afforded no improvement in ee (entries 5 and 6). In examining other bidentate 
ligands with axial chirality, it was discovered that the SYNPHOS class of ligands gave 
excellent ee, albeit with poor yields (entry 9). By switching to SEGPHOS, both yield and 
ee were further improved (entry 10). Increasing the electron density of the ligand was 
hypothesized to enhance reactivity by promoting the initial oxidative addition. 
Fortuitously, by utilizing DTBM-SEGPHOS, the yield was improved to 60% and upon 
further solvent and reaction condition investigations (entries 12-17), benzotricycle 2.2a 
was obtained in 81% yield and 97% ee.  
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Table 2.1. Selected Optimization of Reaction Conditions with Substrate 2.1a. (a) 5 mol % 
Rh precatalyst and 12 mol % ligand were used on a 0.1 mmol scale with 20h reaction 
time. (b) Isolated yield; numbers in parentheses are brsm yield. (c) ee was determined 
using chiral HPLC. (d) Reaction time was 48h. 
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With the optimized reaction conditions in hand, investigations into the substrate 
scope of this transformation were investigated (Table 2.2). Delightedly, a wide variety of 
steric and electronic properties on a number of substrates were investigated and their 
products were found to have both high yields and enantioselectivities.  
Table 2.2 Carboacylation Substrate Scope. Reaction conditions: (a) [Rh(cod)Cl]2 (5 mol 
%), (R)-DTBM-SEGPHOS (12 mol %), dioxane, 133 0C, 48h. (b) Isolated yield; numbers 
in parentheses are brsm yield. (c) ee was determined by chiral HPLC. (d) (R,R)-DIOP / 
THF were used instead. 
 
Altering the electron density of the aromatic ring had little effect on 
enantioselectivity, as ee’s higher than 97% were observed (entries 1-4). An increase in 
the steric bulk of the olefin substituent decreased reactivity, but maintained high optical 
purities in the products formed (entries 5-7). Aryl-olefins also afforded extremely high 
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ee’s and moderate yields (entries 8-11). In certain cases (entries 9 and 13), the DIOP 
ligand system was found to be more efficient for the transformation, increasing both yield 
and ee.  
A proposed catalytic cycle is outlined in Scheme 2.2.  This “cut and sew” 
transformation begins with the oxidative addition of rhodium-I into the 
benzocyclobutenone C1–C2 bond, which is followed by migratory insertion into the olefin 
to give a seven-membered metallocycle, and subsequent reductive elimination to afford 
the desired fused-ring systems.  
 
 
 
 
 
 
 
Scheme 2.2 Proposed Catalytic Cycle. 
 
 With a wide variety of enantiomerically enriched structures in hand, it was 
postulated that a successful catalytic dearomatization reaction would afford fully 
saturated tricycles. Despite its unique elegance, the reduction of poly-substituted, 
electron-rich aromatic rings is challenging when compared to their unhindered and 
electron-deficient counterparts.15 Nevertheless, the effective reduction to multi-
substituted cyclohexanes was achieved as outlined in Scheme 2.3.  
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Scheme 2.3 Catalytic Dearomatization. 
 
Excitingly, these reductions were conducted at near-neutral, room temperature 
conditions and afforded a stereoselective reduction on the convex face of the tricycles 
(likely governed by the quaternary carbon center). This caused the products to adopt a 
“half-cage” structure upon ensuing crystallization. In situations of over-oxidation, a Ley 
oxidation was implemented to ensure ketones were afforded as the sole product.16 This 
reactivity provides a novel method toward accessing chiral, saturated fused ring systems.   
 
2.4 Conclusions 
 
A series of benzocyclobutenone derivatives were constructed with the goal of 
achieving insight into their ability to afford chiral fused rings under rhodium-I catalysis.  
Using a C–C bond activation approach with tethered olefins, the first enantioselective 
rhodium-catalyzed carboacylation was achieved. Isolated yields (40-97%) and excellent 
enantioselectivities (92-99% ee) were obtained for a number of substrates with various 
steric and electronic properties. Successful synthesis of fully saturated poly-fused rings 
was achieved using a catalytic reductive dearomatization approach, offering a unique 
method to prepare multiple stereocenters. These investigations provide a distinct way to 
prepare chiral carbo-frameworks that are nontrivial to access with conventional methods. 
Future work toward discovering more efficient catalyst / ligand combinations, as well as 
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an expansion of the substrate scope for both carboacylation and dearomatization are 
ongoing. In the future, this methodology may act as a new template for the strategic 
synthesis of terpenoid compounds.  
 
2.5 Experimental 
 
Instrumentation 
 
Analytical thin-layer chromatography (TLC) was carried out using 0.2 mm 
commercial silica gel plates (silica gel 60, F254, EMD Chemical). The vials (1 dram, 
15×45 mm with PTFE lined cap attached) were purchased from Qorpak and dried in an 
oven overnight and cooled under a stream of nitrogen prior to use. Infrared spectra were 
recorded on a Nicolet 380 FTIR using a neat thin film technique. High-resolution mass 
spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative 
intensity). Accurate masses are reported for the molecular ion [M+Na]+, [M+H]+, or 
[M+]. Nuclear magnetic resonance spectra (1H NMR and 13C NMR) were recorded with a 
Varian Gemini (400 MHz, 1H at 400 MHz, 13C at 100 MHz). For CDCl3 solutions the 
chemical shifts are reported as parts per million (ppm) referenced to residual protium or 
carbon of the solvents; CHCl3 δ H (7.26 ppm) and CDCl3 δ C (77.16 ppm). Coupling 
constants are reported in Hertz (Hz). Data for 1H NMR spectra are reported as follows: 
chemical shift (ppm, referenced to protium; s = singlet, d = doublet, t = triplet, q = 
quartet, quin = quintet, dd = doublet of doublets, td = triplet of doublets, ddd = doublet of 
doublet of doublets, m = multiplet, coupling constant (Hz), and integration). 
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Synthesis 
 
Unless otherwise noted, all manipulations were carried out under an inert 
atmosphere in a nitrogen-filled glove box or by standard Schlenk techniques. 
Dichloromethane (DCM), diethyl ether (Et2O), tetrahydrofuran (THF), and toluene 
(PhMe) were purified using a Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology). All other reagents were used directly from the supplier without further 
purification. Although in many cases the compounds listed below have been fully 
characterized and reported in literature, they have been included here for completeness. 
 
Experimental Procedures and Characterization Data 
 
Preparation of Benzocyclobutenone Structures for Carboacylation 
 
 A 250-mL, one-necked, round-bottomed flask equipped with a large, elliptical stir 
bar and open to the atmosphere is charged with distilled water (35 mL), THF (35 mL), 5-
isopropyl-benzene-1,3-diol  (3.5 g, 23 mmol) and iodine (7.49 g, 24 mmol), and then 
cooled in an ice-water bath.17 To this open flask is slowly added sodium bicarbonate 
(2.75 g, 25 mmol) in portions by spatula over 5 minutes at 0 °C with vigorous stirring. 
During the addition, vigorous gas evolution (carbon dioxide) is observed. The ice bath is 
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removed and the mixture is allowed to warm to r.t. over 20 minutes and then stirred for 
another 10 minutes, during which time it becomes a brown slurry. The products are 
extracted with ethyl acetate (3 x 50 mL). The combined organic extracts are successively 
washed with 10% aqueous sodium thiosulfate solution and brine, dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to give 2-iodo-5-
isopropylbenzene-1,3-diol as a light yellow oil.  
 
Imidazole (4.9 g, 72 mmol) and TBSCl (5.43 g, 36 mmol) were added to a 
solution of 2-iodo-benzene-1,3-diol in CH2Cl2 (60 mL) at 0 oC. This reaction mixture was 
stirred at r.t. for 1 hour and was quenched by the addition of H2O (50 mL). The reaction 
mixture was extracted with CH2Cl2 (50 mL x 3) and the organic phase was washed with 
brine (60 mL), dried over MgSO4, filtered and concentrated. Purification of the residue 
by flash column chromatography (hexanes:EtOAc, 2:1) provided compound S1 (4.25 g, 
65% for 2 steps). Rf = 0.5 (EtOAc/Hexane = 1/2). 1H NMR (400 MHz, CDCl3): δ 6.53 
(d, J = 2.0 Hz, 1H), 6.29 (d, J = 2.4 Hz, 1H), 5.32 (s, 1H), 2.77 (quin, J = 6.9 Hz, 1H), 
1.20 (d, J = 6.8 Hz, 6H), 1.06 (s, 9H), 0.28 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 
156.0, 155.5, 151.5, 109.0, 105.8, 79.3, 33.8, 25.9, 23.7, 18.4, 4.0. IR: v 3489, 2959, 
2929, 1571, 1425, 1350, 1254, 1192, 1055, 833 cm-1; HRMS calc'd. for C15H26IO2Si+ 
[M+H]+: 393.0747. Found: 393.0742. 
 
A flame-dried 200-mL Schlenk tube equipped with a magnetic stir bar, a nitrogen 
gas balloon and a rubber septum was charged with S1 (1 g, 2.5 mmol) and CH2Cl2 (25 
mL), and the mixture was cooled to –78 °C with a dry ice-acetone bath. Triethyl amine 
(0.43 mL, 3.0 mmol) was added by syringe. Tf2O (0.47 mL, 2.8 mmol) was slowly added 
over 15 minutes via syringe while maintaining the reaction mixture at –78 °C. After 
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stirring for 10 minutes at –78 °C, the reaction mixture was warmed to 0 °C by replacing 
the dry ice-bath with an ice water bath, and stirred for 1 h. The reaction was quenched by 
the slow addition of aqueous ammonium chloride (20 mL), and the aqueous phase was 
extracted with CH2Cl2 (2 × 25 mL). The combined organic extract was successively 
washed with saturated aqueous sodium bicarbonate solution (2 × 25 mL) and brine (2 × 
25 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. Purification of the residue by flash column chromatography (hexanes-EtOAc, 
5:1) provided compound S2 (1.32 g, 98%). Rf = 0.5 (EtOAc/Hexane = 1/5). 1H NMR 
(400 MHz, CDCl3): δ 6.77 (d, J = 1.6 Hz, 1H), 6.67 (d, J =1.2 Hz, 1H), 2.85 (quin, J = 
6.9 Hz, 1H), 1.21 (d, J = 7.2 Hz, 6H), 1.05 (s, 9H), 0.29 (s, 6H). 13C NMR (100 MHz, 
CDCl3): δ 157.3, 151.8, 151.2, 120.3, 117.2, 115.9, 112.8, 83.0, 33.8, 25.8, 23.5, 18.4, -
4.0. IR: v 2962, 2931, 1597, 1559, 1420, 1215, 1141, 1016, 807, 601 cm-1; HRMS 
calc’d. for C16H24F3IO4SSi+ [M]+: 524.0161. Found: 524.0163. 
 
A flame-dried, 200-mL Schlenk flask equipped with a magnetic stirrer bar, a 
nitrogen gas balloon and a rubber septum was charged with 3-((tert-
butyldimethylsilyl)oxy)-2-iodo-5-isopropylphenyl trifluoromethanesulfonate (1.0 g, 1.9 
mmol). The flask was flushed with nitrogen, THF (50 mL) and S3 (0.72 mL, 3.24 mmol) 
were added by syringe, and the mixture was cooled to –78 °C with a dry ice-acetone bath. 
A solution of nBuLi in hexanes (2.5 M, 1.5 mL, 3.8 mmol) was added to the reaction 
mixture over 20 minutes via syringe. The reaction mixture was further stirred for 5 
minutes at –78 °C, then water (5 mL) was added drop wise. After warming to r.t., water 
(40 mL) was added, and the products were extracted with ether (3 × 40 mL). The 
combined organic extracts were washed with brine (40 mL), dried over anhydrous 
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sodium sulfate, filtered, and concentrated under reduced pressure to give the crude 
product as a light yellow oil. This was used directly for the next step without further 
purification.  
 
A 250-mL, round-bottomed flask equipped with a magnetic stirrer bar, was 
charged with this crude product in CH3CN (40 mL) and the mixture was cooled to 0 °C in 
an ice-water bath. Aqueous HF (27.6M, 0.7 mL, 19 mmol) was slowly added during 2 
minutes via syringe. The mixture was warmed to r.t. over 20 minutes, then stirred for 
another 13h at 40 °C. The reaction mixture was carefully poured into saturated aqueous 
sodium bicarbonate solution (30 mL), and the products are extracted with ethyl acetate (3 
× 30 mL). The combined organic extract was successively washed with saturated aqueous 
sodium bicarbonate solution (30 mL) and brine (30 mL), dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure to give a yellow oil residue. 
The residue was purified by column chromatography on silica gel to give 315 mg of S4 
as light yellow oil in 93% yield. Rf = 0.4 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, 
CDCl3): δ 9.25 (s, 1H), 6.89 (s, 1H), 6.67 (s, 1H), 3.84 (s, 2H), 2.90 (quin, J = 6.9 Hz, 
1H), 1.24 (d, J = 6.4 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 188.3, 162.2, 150.6, 
149.4, 129.8, 114.6, 113.3, 50.3, 35.3, 23.6. IR: v 3337, 2962, 2927, 1735, 1612, 1454, 
1302, 1147, 1049, 853 cm-1; HRMS calc’d. for C11H13O2+ [M+H]+: 177.0916. 
Found: 177.0910. 
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2.1c 
3-chloro-2-methylprop-1-ene (0.14 mL, 1.4 mmol) was added in one portion to a 
solution of acetone (15 mL) containing S4 (100 mg, 0.56 mmol), potassium carbonate 
(392 mg, 2.8 mmol) and potassium iodide (283 mg, 1.7 mmol). The reaction mixture was 
heated to reflux for overnight. Then the reaction was quenched with aqueous ammonium 
chloride (10 mL). The aqueous phase was extracted with ethyl acetate (2 × 10 mL) and 
the combined organic extract was washed with brine (10 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to give a colorless 
residue. The residue was as purified by column chromatography on silica gel to give 120 
mg (92%) of 2.1c as colorless oil. Rf = 0.6 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, 
CDCl3): δ 6.89 (s, 1H), 6.72 (s, 1H), 5.05 (d, J = 0.8 Hz, 1H), 4.93 (d, J = 1.2 Hz, 1H), 
4.80 (s, 2H), 3.83 (s, 2H), 2.90 (quin, J = 7.0 Hz, 1H), 1.82 (s, 3H), 1.24 (d, J = 6.8 Hz, 
6H). 13C NMR (100 MHz, CDCl3): δ 184.4, 160.8, 152.5, 150.5, 140.6, 130.2, 114.4, 
113.6, 112.6, 75.5, 50.6, 35.1, 23.7, 19.4. IR: v 2962, 2926, 1762, 1609, 1571, 1448, 
1329 1223, 1061, 914 cm-1; HRMS calc’d. for C15H19O2+ [M+H]+: 231.1385. Found: 
231.1385. 
 
 
 
 
 
 
2.1a, 2.1b, 2.1d, 2.1e, 2.1h, and 2.1l matched the data that was reported in the literature.18 
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Allyl alcohols S5a-e are known compounds and were synthesized according to 
literature procedure.19 
 
 
Preparation of C–C Activation Precursors for Carboacylation 
 
A flame-dried Schlenk flask equipped with a magnetic stirrer bar was charged 
with benzocyclobutenone (1 equiv.), PPh3 (1.1 equiv.), and R’CH2OH (1.1 equiv.). The 
flask was degassed three times under nitrogen before THF was added via cannula. Then 
DIAD (1.1 eq.) was added via syringe drop wise to the solution. The reaction was heated 
to reflux and monitored by TLC. When the reaction was finished, it was concentrated 
under reduced pressure. The residue was purified by column chromatography on silica 
gel to yield the desired alkylation product.  
 
 
 
 
 
2.1f  
 
Compound 2.1f was isolated as a yellow oil in 98% yield from benzocyclobutenone and 
S5a. Rf = 0.7 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.43 (dd, J = 8.4, 7.2 
Hz, 1H), 7.02 (d, J = 7.2 Hz, 1H), 6.86 (dd, J = 8.4, 0.8 Hz, 1H), 5.12 (d, J = 1.6 Hz, 1H), 
5.00 (t, J = 1.0 Hz, 1H), 4.91 (s, 2H), 3.92 (s, 2H), 2.46 (quin, J = 6.9 Hz, 1H), 1.12 (d, J 
= 6.8 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 185.0, 152.4, 150.5, 150.4, 137.7, 132.4, 
116.3, 115.1, 109.9, 74.0, 51.2, 31.1, 21.6. IR: v 2962, 2928, 1769, 1604, 1574, 1474, 
1275, 1129, 1052, 783 cm-1; HRMS calc’d. for C14H15O2 - [MH]-: 215.1072. Found: 
215.1073. 
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2.1g 
 
Compound 2.1g was isolated as a yellow oil in 93% yield from benzocyclobutenone and 
S5b. Rf = 0.7 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.42 (dd, J = 8.6, 7.0 
Hz, 1H), 7.01 (d, J = 7.2 Hz, 1H), 6.84 (d, J = 8.8 Hz, 1H), 5.10-5.09 (m, 1H), 4.99 (d, J 
= 0.8 Hz, 1H), 4.89 (s, 2H), 3.90 (s, 2H), 2.54 (quin, J = 8.6 Hz, 1H), 1.92-1.84 (m, 2H), 
1.74-1.65 (m, 2H), 1.64-1.53 (m, 2H), 1.51-1.39 (m, 2H). 13C NMR (100 MHz, CDCl3): 
δ 184.9, 152.4, 150.5, 147.8, 137.7, 132.4, 116.3, 115.1, 109.8, 74.7, 51.2, 43.3, 31.4, 
24.8. IR: v 2954, 2868, 1768, 1603, 1573, 1474, 1275, 1128, 1052, 782 cm-1; HRMS 
calc’d. for C16H19O2+ [M+H]+: 243.1385. Found: 243.1385. 
 
 
2.1i 
 
Compound 2.1i was isolated as a colorless oil in 89% yield from benzocyclobutenone and 
S5c. Rf = 0.65 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.46-7.42 (m, 3H), 
7.18 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 6.8 Hz, 1H), 6.86 (d, J = 8.8 Hz, 1H), 5.59 (d, J = 
0.8 Hz, 1H), 5.43 (dd, J = 2.6, 1.4 Hz, 1H), 5.31 (d, J = 0.8 Hz, 2H), 3.95 (s, 2H), 2.36 (s, 
3H). 13C NMR (100 MHz, CDCl3): δ 185.2, 152.3, 150.7, 142.6, 137.9, 137.8, 135.2, 
132.7, 129.3, 126.0, 116.6, 115.4, 114.0, 73.9, 51.4, 21.3. IR: v 2921, 1765, 1603, 1572, 
1474, 1447, 1272, 1129, 1053, 824 cm-1; HRMS calc’d. for C18H17O2+ [M+H]+: 
265.1229. Found: 265.1223. 
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2.1j 
 
Compound 2.1j was isolated as a sticky oil in 98% yield from benzocyclobutanone and 
S5d. Rf = 0.4 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.48-7.42 (m, 3H), 
7.05 (dd, J = 7.2, 0.4 Hz,1H), 6.91-6.88 (m, 2H), 6.86 (dd, J = 8.4, 0.4 Hz, 1H), 5.52 (d, J 
= 0.8 Hz, 1H), 5.38 (d, J = 1.2 Hz, 1H), 5.29 (d, J = 0.8 Hz, 2H), 3.95 (d, J = 0.8 Hz, 2H), 
3.82 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 185.1, 159.5, 152.1, 150.5, 142.0, 137.8, 
132.5, 130.5, 127.2, 116.5, 115.3, 113.8, 113.0, 73.8, 55.3, 51.2. IR: v 2961, 2928, 2832, 
1762, 1603, 1570, 1264, 1125, 1052, 835 cm-1; HRMS calc’d. for C18H16O3 [M]+: 
280.1099. Found: 280.1096. 
 
2.1k 
 
Compound 2.1k was isolated as a light yellow oil in 90% yield from benzocyclobutanone 
and S5e. Rf = 0.6 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.65-7.60 (m, 
4H), 7.45 (dd, J = 8.2, 7.0 Hz, 1H), 7.07 (d, J = 6.8 Hz, 1H), 6.85 (d, J = 8.8 Hz, 1H), 
5.68 (d, J = 0.8 Hz, 1H), 5.58 (d, J = 0.8 Hz, 1H), 5.33 (s, 2H), 3.96 (s, 2H). 13C NMR 
(100 MHz, CDCl3): δ 152.0, 150.7, 141.9, 141.7, 138.0, 132.6, 129.9, 126.6, 125.6, 
125.57, 125.53, 122.9, 116.9, 116.6, 115.8, 73.5, 51.4. IR: v 2987, 2359, 1770, 1603, 
1574, 1475, 1328, 1121, 1069, 847 cm-1. HRMS calc’d. for C18H13O2F3+ [M]+: 318.0868. 
Found: 318.0869. 
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S6 was synthesized from commercially available Methyl 3,5-dihydroxybenzoate in 65% 
overall yield according to literature. A flame-dried, 200-mL Schlenk flask equipped with 
a magnetic stirrer bar, a nitrogen gas balloon and a rubber septum was charged with S6 
(150 mg, 0.31 mmol). The flask was flushed with nitrogen, THF (15 mL) and S3 (0.11 
mL, 0.51 mmol) were added by syringe, and the mixture was cooled to –78 °C with a dry 
ice-acetone bath. A solution of n-BuLi in hexanes (2.5 M, 0.4 mL, 0.93 mmol) was added 
to the reaction mixture over 20 minutes via syringe. The reaction mixture was further 
stirred for 5 minutes at –78 °C, then water (5 mL) was added drop wise. After warming to 
r.t., water (10 mL) was added, and the products were extracted with ether (3 × 15 mL). 
The combined organic extract was washed with brine (20 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to give the crude 
product as a yellow oil. This was used directly for the next step without further 
purification. 
 
A 250-mL, round-bottomed flask equipped with a magnetic stirrer bar was 
charged with this crude product in CH3CN (15 mL) and the mixture was cooled to 0 °C in 
an ice-water bath. Aqueous HF (27.6M, 0.11 mL, 3.1 mmol) was slowly added over 2 
minutes via syringe. The mixture was warmed to r.t. over 20 minutes, then stirred for 
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another 13h at 40 °C. The reaction mixture was carefully poured into saturated aqueous 
sodium bicarbonate solution (15 mL), and the products are extracted with ethyl acetate (3 
× 15 mL). The combined organic extract was successively washed with saturated aqueous 
sodium bicarbonate solution (20 mL) and brine (20 mL), dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure to give a yellow oil residue. 
The residue was purified by column chromatography on silica gel to give 83 mg of 2.1m 
as a yellow oil in 80% yield. 
 
Rf = 0.7 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): δ 7.04 (s, 1H), 6.90 (s, 1H), 
5.06 (s, 1H), 4.94 (s, 1H), 4.82 (s, 2H), 3.86 (s, 2H), 1.83 (s, 3H), 1.79-1.71 (m, 4H), 
1.28-1.21 (m, 6H), 1.01-0.97 (m, 2H), 0.83 (t, J = 6.6 Hz, 6H). 13C NMR (100 MHz, 
CDCl3): δ 184.5, 158.5, 152.1, 150.1, 140.5, 130.4, 113.4, 112.7, 112.5, 77.5, 75.5, 50.7, 
42.9, 25.5, 23.0, 19.4, 14.0. IR: v 3493, 2956, 2933, 1757, 1610, 1571, 1449, 1142, 1068, 
905 cm-1; HRMS calc’d. for C21H31O3+ [M+H]+: 331.2273. Found: 331.2274. 
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Condition A for the Rh-catalyzed C−C Activation (Reactions were performed at 
0.1~0.2 mmol scale and 0.1 M concentration): 
 
In a nitrogen-filled glove box, a 1 dram vial was charged with 5 mol% 
[Rh(cod)Cl]2 and 12 mol% (R,R)-DIOP. A solution of starting material in THF (0.1 M) 
was added and the 1 dram vial was capped and the solution was maintained at 133 °C for 
12 h. The reaction was removed from the glove box and purified by flash 
chromatography. 
 
Condition B for the Rh-catalyzed C−C Activation (Reactions were performed at 
0.1~0.2 mmol scale and 0.1 M concentration): 
 
In a nitrogen filled glove box, a 1 dram vial was charged with 5 mol% 
[Rh(cod)Cl]2 and 12 mol% (R)-DTBM-SEGPHOS. A solution of starting material in 
dioxane (0.1 M) was added and the 1 dram vial was capped and the solution was 
maintained at 133 °C for 48 h. The reaction was removed from the glove box and purified 
by flash chromatography. 
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Chapter 3: Modular Catalytic Systems to Selectively Access Fused 
Rings 
3.1 Introduction 
 
Buoyed by the aforementioned success utilizing C–C bond activation to access 
fused rings, a logical extension of this work was to investigate changes in the unsaturated 
linkages of our model substrates. In particular, by using allenes or dienes as the migratory 
insertion species following the oxidative addition of rhodium into the 
benzocyclobutenone, subsequent reductive elimination would afford fused ring systems 
that retained unsaturated functionality (in the form of an olefin). Wender’s work suggests 
the compatibility of allene substrates under rhodium-I catalysis to afford larger ring 
systems with inherent unsaturation.20 Furthermore, it was postulated that by controlling a 
direct or decarbonylative reductive elimination a more diverse array of ring systems from 
unified starting materials could be accessed. This general approach, in the most basic 
sense, would enable access to a great diversity of medium-sized ring scaffolds difficult to 
access by conventional methods.  
 
3.2 Research Objectives 
 
It is proposed that due to the success of metal-mediated olefin insertions into 
benzocyclobutenones, varying the pendant unsaturated linker to include allenes or dienes 
will greatly expand the applicable scope of C–C activation. Herein, the aim is to further 
investigate various unsaturated ether-linked benzocyclobutenones and to develop a 
library of rhodium-mediated cyclized products that contain strategically placed 
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conjugation units that will enhance the inherent reactivity and functionality of the formed 
compounds. Studies into varying both the steric and electronic nature of substrates and 
catalyst/ligand system employed may lead to unique product formation and unveil 
mechanistic insights. 
 
3.3 Results and Discussion 
 
The early investigations into this portion of work studied the reactivity of allenes 
(whose syntheses are outlined in later supplemental information) in novel metal-mediated 
reactions. Scheme 3.1 highlights the scope of reactive substrates 3.1-3.4a investigated, 
whose construction stems from similar reacting partners and chemical sequences as 
outlined in Chapter 2.  
 
  
 
Scheme 3.1 Scope of Allene Substrates Investigated. 
 
 It was expected that our transition-metal catalyzed step would yield promising 
polyfused rings containing units of unsaturation, thereby expanding upon previous group 
precedent. Initial investigations discovered that the major products of the general reaction 
conditions were isomerizations of the allenes into their more favored diene products.
21
 A 
significant thrust of work was performed using an exhaustive list of various [Rh
I
] 
catalysts; investigations also included commercially available cationic [Rh] species. 
Ligands screened included general bi-dentate phosphine ligands (e.g. dppm, dppe, dppp, 
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dppb), chiral bi-dentate ligands (e.g. DIOP) and mono-dentate ligands (e.g. P(Cy)3, 
P(C6F5)3). As evidenced by our group’s precedent, the use of Lewis acids (ZnCl2) was 
shown to activate the carbonyl moiety and aid in C–C activation. However, when tested 
with the allene substrates in question no additional reactivity toward fused ring formation 
was observed.  Attempts to decrease the requisite amount of kinetic energy for this 
reaction by lowering the temperature to 100 
o
C also proved unsuccessful, as there was no 
reactivity observed, while increasing temperatures beyond 150 
o
C afforded 
decomposition of the starting materials. Future work will focus on the discovery and 
application of a new rhodium catalyst that will promote the desired C–C activation. 
 Inspired by the inconclusive results of the rhodium-mediated allene insertions, 
simple diene substrates were generated (detailed syntheses provided in supplemental 
information) and investigated under general C–C activation conditions as outlined in 
Scheme 3.2. While the less substituted diene compound 3.5a afforded isomerized starting 
material akin to the allene investigations under a variety of reaction conditions, it was 
discovered that not only did compound 3.6a afford fused-ring products; the resultant 
tricycles were reaction-controlled. 
 
 
 
 
 
 
Scheme 3.2 Investigations into Diene Linkages. 
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It was hypothesized that the installation of an alkyl substituent, in this case a 
methyl group at the ∂-position of the ether functional chain, would aid in the 
minimization of isomerization at elevated temperatures. Thus, the model compound 3.6a 
was further investigated in hopes of optimizing reaction conditions (Table 3.1). 
 
Table 3.1 Initial Optimization Conditions for Diene Cyclization.  
 
While by no means exhaustive, Table 3.1 highlights some current major 
breakthroughs of this project. A significant amount of testing was attempted using 
[Rh(cod)Cl]2 as the precatalyst (adapted from our previous studies on alkene activation) 
as it was determined to afford the best conversion of starting materials. Unfortunately, 
reaction additives (bidentate phosphorous ligands or otherwise) were found to 
significantly inhibit the formation of the desired products (in particular, the [6,5,7] fused 
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tricycle. After re-screening a variety of metal catalysts, an ideal catalyst system was later 
realized utilizing [Rh(acac)(CO)2] (Table 3.2). 
Table 3.2 Precatalyst Reinvestigation for Diene Cyclization. 
 
With the new precatalyst system in hand, a variety of reaction effects were again 
investigated and summarized below (Table 3.3). Fortuitously, the ability to decrease the 
reaction temperature from 133 
o
C to 80 
o
C was most notably discovered, and this has 
provided a promising, if not currently limited outlook for this project. Using 
[Rh(acac)(CO)2] allows the reaction to proceed at lower temperatures, but with longer 
reaction times and slightly lower conversions of the starting material.  With a more 
optimal precatalyst system discovered utilizing acetylacetonate (acac) ligands, catalysts 
containing varying acac ligands were investigated and discovered to alter selectivities of 
compounds (3.6b) and (3.6d), albeit decreasing the overall conversion. While this 
transformation is fundamentally interesting, investigations into acac-based catalyst 
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systems were not further studied. Unfortunately, the addition of nitrogen or phosphorous 
based mono- and bi-dentate ligands (with and without additional additives) often afforded 
conversions and yields lower than only the precatalyst system, further limiting the 
reaction scope. Surprisingly, certain electron deficient ligands (most notably P(C6F5)3) 
facilitated reaction progression, albeit with insignificant change in product selectivity or 
yield. Additives such as Lewis acids or radical inhibitors, regardless of the catalyst 
system employed, showed decreased reactivities. Attempts to selectively foster 
decarbonylation products (3.6c) or carbonylation products (3.6d) (through continued 
argon bubbling or sealed CO pressure, respectively) proved unsuccessful. Under argon 
bubbling lower yields of 3.6c were observed, while under a sealed CO atmosphere there 
was no evidence of reactivity, likely caused by the poisoning of the precatalyst.  
Table 3.3 Selected Optimization Conditions for Diene Cyclization. 
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To further investigate the scope of this transformation, a variety of polyfused 
rings were synthesized (detailed in supplemental information) and the results of the 
reactions are highlighted in Table 3.4. 
Table 3.4 Selected Expansion of the Substrate Scope. 
Unfortunately, while these are promising results toward an assortment of 
functionalized molecules, the modifications required for the rhodium-mediated key step 
underscore that the process is currently not universal, as the results outlined above arise 
from different catalysts and ligands on a case by case basis. These results therefore 
reinforce the importance of further optimizing the current varied reaction conditions into 
a unified method. 
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3.4 Conclusions 
The preliminary work on allene and diene containing benzocyclobutenone 
derivatives displayed the ability to selectively cleave carbon-carbon bonds in order to 
construct a diverse array of polyfused ring systems from a single unified starting material. 
C–C activation was discovered to occur at significantly milder reaction conditions than 
previously reported.14 Future work in this chapter will focus on both the continued 
optimization of reaction conditions and the expansion of the substrate scope for C–C 
activation; in particular, the versatility afforded by diversifying the unsaturated substrates 
tethered to the benzocyclobutenone backbone. Likewise, a detailed study into 
enantioselective ring formations, expansion to cheaper transition metals (e.g. cobalt), 
even milder reaction conditions, and a practical application to a class of natural products 
are all viable directions for this unique methodology. 
 
3.5 Experimental 
 
Preparation of Allene and Diene Substrates for Fused Ring Formation 
 
Allene alcohols S6a-d are known compounds and were synthesized according to 
literature procedure.22,23,24 
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A flame-dried Schlenk flask equipped with a magnetic stirrer bar was charged 
with benzocyclobutenone (1.0 mmol, 1 equiv.), PPh3 (1.1 equiv.), and S6 (1.1 equiv.). 
The flask was degassed three times under nitrogen before THF (0.1 M, 10 mL) was 
added via cannula. Then DIAD (1.1 eq.) was added via syringe drop wise to the solution. 
The reaction was heated to reflux and monitored to completion by TLC (1-12 h). When 
the reaction was finished, it was concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel to yield the desired allene alkylation 
product. 
 
3.1a 
 
3.1a was isolated as a yellow oil in 72% yield. Rf=0.73 (1/1 Pentanes/Et2O). 
1
H NMR 
(CDCl3, 400 MHz) 7.41 (t, J=8 Hz, 1H), 7.02 (d, J=8 Hz, 1H), 6.82 (d, J=8 Hz, 1H), 
5.43-5.36 (m, 1H), 4.92-4.89 (m, 2H), 4.85-4.82 (m, 2H), 3.91 (s, 2H). 
13
C NMR 
(CDCl3, 101 MHz) 210, 185, 152, 151, 138, 132, 116, 115, 87, 70, 51, 30.  
 
 
3.2a 
 
3.2a was was isolated as a pale yellow oil in 45% yield. Rf = 0.70 (4/1 Hexanes/EtOAc). 
IR 2926, 2860, 2333, 1765, 1457 cm
-1
. 
1
H NMR (CDCl3, 400 MHz) 7.42 (t, J= 8 Hz, 
1H) 7.02 (d, J= 8 Hz, 1H) 6.86 (d, J=8 Hz, 1H), 5.35 (d, J=8 Hz, 2H), 5.21 (s, 1H), 5.07 
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(d, J= 8 Hz, 3H), 3.92 (s, 2H), 2.31 (q, J= 8 Hz, 2H), 1.09 (t, J=8 Hz, 3H). 
13
C NMR 
(CDCl3, 101 MHz). . HRMS for C15H16O2 Calc’d 228.1 Found 228.1149.  
 
3.3a  
 
3.3a was isolated as a yellow oil in 60 % yield.  Rf=0.70 (1/1 Pentanes/Et2O). 
1
H NMR 
(CDCl3, 400 MHz) 7.40 (t, J=8 Hz, 1H), 6.99 (d, J=8 Hz, 1H), 6.78 (d, J=8 Hz, 1H), 
5.22-5.15 (m, 1H), 4.69 (q, 2H), 4.43 (t, 2H), 3.89 (s, 2H), 2.50-2.43 (m, 2H). 
13
C NMR 
(CDCl3, 101 MHz) 209, 185, 152, 151, 138, 132, 116, 115, 86, 75, 71, 51, 29.  
 
3.4a 
3.4a was isolated as a pale yellow oil in 66% yield. Rf=0.68 (4/1 Hexanes/EtOAc) IR 
2973, 2918, 2845, 1760, 1597, 1570, 1454, 1275 cm
-1
. 
1
H NMR (CDCl3, 400 MHz) 7.40 
(t, J=8 Hz, 1H), 6.98 (d, J=8 Hz, 1H), 6.78 (d, J=8 Hz, 1H), 5.02-4.99 (m, 1H), 4.43 (t, 
J= 8 Hz, 2H), 3.89 (s, 2H), 2.40 (q, J= 8 Hz, 2H), 1.64 (s, 6H). 
13
C NMR (CDCl3, 101 
MHz) 185, 153, 151, 137, 132, 116, 115, 96, 85, 72, 51, 30, 20.  
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Compounds 3.5a and 3.6a were prepared in identical fashion to compounds 
3.1-4a using literature known diene alcohols S7a and S7b as precursors (vide 
supra).25,26 
 
 
 
 
3.5a 
 
3.5a was isolated as an amorphous white solid in 66% yield. Rf=0.68 (4/1 
Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 7.40 (t, J= 8 Hz, 1H) 6.99 (d, J= 8 Hz, 
1H) 6.80 (d, J=8 Hz, 1H), 6.40-6.29 (m, 2H) 5.94-5.84 (m, 1H), 5.24 (d, J= 16 Hz, 1H), 
5.12 (d, J=8 Hz, 1H), 4.94 (d, J=8 Hz, 2H), 3.91 (s, 2H). 
13
C NMR (CDCl3, 101 MHz) 
185, 150, 138, 136, 134, 126, 119, 116, 115, 114, 113, 72, 51. HRMS for C13H12O 
Calc’d 200.10 Found 200.0837 
 
3.6a 
 
3.6a was isolated as an amorphous yellow solid in 83% yield. Rf=0.58 (4/1 
Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 7.42 (t, J= 8 Hz, 1H) 7.01 (d, J= 8 Hz, 
1H) 6.83 (d, J=8 Hz, 1H), 6.47 (d, J=16 Hz, 1H), 5.87-5.80 (m, 1H), 5.01 (s, 2H), 4.97 
(d, J= 8 Hz, 2H) 3.91 (s, 2H), 1.85 (s, 3H). 
13
C NMR (CDCl3, 101 MHz). 185, 152, 150, 
151, 137, 132, 123, 118, 116, 115, 114, 72, 50, 18. IR 3077, 2918, 1764, 1605, 1566, 
1446, 1268, 1047 cm
-1
. HRMS for C14H14O2 Calc’d 214.10 Found  214.0993.  
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Condition A for the Rh-catalyzed C−C Activation (Reactions were performed at 
0.1~0.2 mmol scale and 0.1 M concentration): 
 
In a nitrogen-filled glove box, a 1 dram vial was charged with 5 mol% 
[Rh(acac)(CO)2]. A solution of starting material in THF (0.1 M) was added and the 1 
dram vial was capped and the solution was maintained at 133 °C for 12 h. The reaction 
was removed from the glove box and purified by flash column chromatography. 
 
 
3.6b 
 
3.6b was isolated as a pale yellow oil in 25% yield. 
1
H NMR (CDCl3, 400 MHz) 7.13 (t, 
J= 8 Hz, 1H) 6.69 (d, J= 4 Hz,2H), 5.05 (s, 1H) 4.80 (dd, J= 4Hz, 2H), 4.16 (t, J= 8 Hz, 
1H), 3.91 (q, J= 8 Hz, 1H) 3.60 (d, J= 8 Hz, 2H), 3.01 (d, J= 8 Hz, 1H), 1.78 (d, J= 1 
Hz, 3H). 
13
C NMR (CDCl3, 101 MHz) 208, 159,, 140, 131, 130, 127, 119, 116, 107, 78, 
62, 42, 40, 20. 
 
 3.6c 
 
3.6c was isolated as a pale yellow oil in 10% yield. 
1
H NMR (CDCl3, 400 MHz) 7.13 (t, 
J= 4 Hz, 1H) 6.48 (d, J= 1 Hz, 2H), 5.35 (s, 1H) 4.80 (q, J= 8Hz, 1H), 4.39 (bt, 1H), 
4.10 (q, J= 8 Hz, 1H) 3.03-2.97 (m, 1H) 2.99-2.93 (m, 1H) 2.66-2.59 (m, 1H) 2.38-2.36 
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(m, 1H) 1.75 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) 159, 139, 138, 138, 125, 123, 121, 
108, 77, 40, 32, 30, 26. 
 
 
3.6d 
 
3.6d was isolated as a pale yellow oil in 16% yield. Rf =0.17 (5/1 Hexanes/EtOAc) 
1
H 
NMR (CDCl3, 400 MHz) 7.07 (t, J= 6 Hz, 1H) 6.73 (d, J= 4 Hz, 1H), 6.66 (d, J= 4 Hz, 
1H) 5.47 (dd, J= 8Hz, 1H), 4.77 (t, J= 10 Hz, 1H), 4.31 (t, J= 10 Hz, 1H) 4.22 (q, J= 1 
Hz, 1H), 3.92 (d, J= 8 Hz, 1H), 3.69 (d, J= 8 Hz, 1H), 3.26 (d, J= 12 Hz, 1H), 3.15 (d, 
J= 12 Hz, 1H), 1.89 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) 207, 160, 133, 132, 129, 127, 
126, 122, 109, 48, 47, 42, 30, 26. IR 2918, 2841, 1984, 1702, 1582, 1446, 1241 cm
-1 
HRMS for C14H14O2 Calc’d 214.10 Found 214.0994. 
 
Synthesis of Compounds 3.7a-2.12a 
 
 
Alcohols S8a-d are known compounds and were synthesized according to 
literature procedure.27,28,29,30 Together with the literature known diene alcohol S7a, these 
compounds were coupled to benzocyclobutenone following similar procedures previously 
outlined vide supra). 
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3.7a 
 
3.7a was synthesized from S8a and benzocyclobutanone and was isolated as a pale 
yellow oil in 90% yield. Rf = 0.59 (4/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 
7.40 (t, J= 8 Hz, 1H) 6.98 (d, J= 8 Hz, 1H) 6.81 (d, J=8 Hz, 1H), 4.20 (d, J=1 Hz, 2H), 
3.87 (s, 2H) 1.27-1.23 (m, 1H), 0.62-0.60 (m, 2H), 0.39-0.37 (m, 2H). 
13
C NMR (CDCl3, 
101 MHz). 185, 152, 150, 137, 132, 116, 115, 55, 51, 10, 3. IR 3074, 3004, 2922, 1764, 
1601, 1566, 1469 cm
-1
. HRMS for C12H12O2 Calc’d 188.0837 Found 188.0839. 
 
 
3.8a 
3.8a was synthesized from S8b and benzocyclobutanone and was isolated as a pale 
yellow oil in 75% yield. Rf=0.39 (5/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 
7.39 (t, J= 8 Hz, 1H) 6.98 (d, J= 8 Hz, 1H), 6.78 (d, J= 8 Hz, 1H) 6.15-6.11 (m, 1H), 
5.77 (d, J= 8 Hz, 1H), 4.89 (d, J= 4 Hz, 2H) 3.87 (s, 2H), 1.90 (s, 3H) 
13
C NMR (CDCl3, 
101 MHz). 185, 152, 150, 137, 135, 132, 116, 115, 113, 87, 71, 69, 51, 4. IR 2027, 2920, 
2842, 2223, 1760, 1599 cm
-1
. HRMS for C14H12O2 Calc’d 212.1 Found 211.0759.   
 
 
3.9a 
3.9a was synthesized from S8c and benzocyclobutanone and was isolated as an 
amorphous white solid in 91% yield. Rf=0.50 (5/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 
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400 MHz) 7.42 (t, J= 8 Hz, 1H) 7.01 (d, J= 4 Hz, 1H), 6.84 (d, J= 8 Hz, 1H) 6.00 (s, 
1H), t5.00 (s 1H), 4.83 (d, J= 8 Hz, 3H) 3.90 (s, 2H), 1.90 (s, 3H) 1.85 (s, 3H). 
13
C NMR 
(CDCl3, 101 MHz). 185, 152, 150, 141, 138, 132, 130, 116, 115, 114, 78, 51, 22, 15. IR 
3077, 2965, 2926, 2852, 1760, 1601 cm
-1
. HRMS for C15H16O2 (M+Na)+  Calc’d 228.1 
Found 251.1036. 
 
3.10a 
 
 
3.10a was synthesized from S7a and benzocyclobutanone and was isolated as a clear oil 
in 31% yield. Rf=0.55 (5/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 7.43 (t, J= 4 
Hz, 1H) 7.01 (d, J= 4 Hz, 1H) 6.85 (d, J=8 Hz, 1H), 6.49 (d, J=16 Hz, 1H), 5.88-5.84 (m, 
1H), 5.01 (s, 2H), 4.99 (d, J= 8 Hz, 1H) 4.19 (q, J= 8 Hz, 1H), 1.87 (s, 3H).1.45 (d, J= 8 
Hz, 3H)  
13
C NMR (CDCl3, 101 MHz). 189, 157, 152, 141, 136, 130, 124, 117, 116, 114, 
72, 58, 18, 15. IR 3084, 2962, 2925, 2867, 1757, 1603, 1270 cm
-1
.HRMS for C15H16O2 
Calc’d 228.1 Found  228.1150.  
 
 
3.11a 
 
3.11a was synthesized from S7a and benzocyclobutanone and was isolated as a clear oil 
in 76% yield. Rf=0.39 (5/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 6.85 (s, 1H) 
6.66 (s, 1H), 6.48 (d, J= 8 Hz, 1H) 5.86-5.82 (m, 1H), 5.02 (s, 2H), 4.96 (d, J= 8 Hz, 
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2H), 3.85 (s, 2H) 2.37 (s, 3H) 1.86 (s, 3H). 
13
C NMR (CDCl3, 101 MHz). 185, 152, 150, 
149, 141, 136, 130, 123, 117, 116, 116, 72, 50, 22, 18. IR 3081, 2922, 1806, 1756, 1617, 
1570, 1283 cm
-1
. HRMS for C15H16O2 (M+Na)+  Calc’d 228.1 Found 251.1039  
 
 
 
3.12a  
3.12a was synthesized from S8d and benzocyclobutanone and was isolated as a pale 
yellow oil in 77% yield. Rf=0.60 (5/1 Hexanes/EtOAc). 
1
H NMR (CDCl3, 400 MHz) 
7.44 (t, J= 8 Hz, 1H) 7.05 (d, J= 8 Hz, 1H), 6.86 (d, J= 8 Hz, 1H) 5.27 (d, J=24 Hz, 2H), 
5.14 (s, 2H) 3.92 (s, 2H), 1.86 (s, 3H). 
13
C NMR (CDCl3, 101 MHz). 185, 151, 150, 137, 
132, 123, 116, 115, 88, 82, 60, 51, 23. IR 2922, 1765, 1602, 1575, 1474, 1269 cm
-1
. 
HRMS for C14H12O2 (M+Na)+ Calc’d 212.1 Found 235.0629. 
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Chapter 4: Decarbonylative Coupling to Access Functionalized 
Spirocycles 
(With Dr. Tao Xu) 
 
4.1 Introduction 
 
As previously evidenced, catalytic C–C activation and subsequent 
functionalization provides a unique method toward developing complex structures that 
are otherwise
 
non-trivial to access. In this creative vein, C–C activation that would 
involve a decarbonylative process is of significant synthetic value because it allows for 
the formation of compounds lacking a carbonyl moiety from their more readily available 
ketone precursors.
31
 Nevertheless, this decarbonylative sequence has heretofore been 
limited in its reaction scope, using either of the two generally established methods 
exhibited below: the direct extrusion of CO to afford hydrocarbon products or the 
coupling with extremely simple olefin partners and subsequent CO elimination (Figure 
4.1).
32,33
  
 
 
Figure 4.1 C–C Activation via Decarbonylation. 
 
The discovery of novel, synthetically useful transformations is thusly of great 
importance. Given the ubiquity of carbonyl compounds in synthesis, these 
transformations would create a unique synthetic sequence that results in the removal of 
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carbonyl groups upon the formation of desired products. Based upon our recent 
developments of the intramolecular carboacylation between benzocyclobutenones and 
olefins (namely the oxidative addition of rhodium-I into the benzocyclobutenone C1–C2 
bond, followed by migratory insertion into a tethered olefin and subsequent reductive 
elimination to afford fused-ring systems) it was postulated if a  β-H elimination/ 
decarbonylation sequence could be preferentially promoted to construct spirocyclic 
systems. Given that spirocycles are important structural motifs often found in bioactive 
natural products (Figure 4.2), and that efficient synthesis of functionalized spirocycles is 
challenging,
 
this decarbonylative C–C activation strategy would provide a 
complementary approach to the previous spirocyclization methods.
34,35 
 
 
 
 
 
Figure 4.2 Representative Spirocyclic Natural Products. 
 
4.2 Research Objectives 
 
In this chapter, we outline our development of a rhodium-catalyzed 
decarbonylative spirocyclization via an intramolecular coupling between multi-
substituted olefins and benzocyclobutenones by combining C–C activation, pendant 
olefin insertion, β-H elimination and CO extrusion in one catalytic cycle. The greatest 
challenge was the preferential β-H elimination and subsequent decarbonylation sequence 
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over reductive elimination, a challenge that was overcome by utilizing an ideal catalyst 
and ligand system (Figure 4.3). 
Figure 4.3 Selective Product Formation. 
 
Encouraged by the recent work of Tang, it was hypothesized that the use of π-
acidic ligands would benefit spirocycle formation.
36
 Two explanations for the reactivity 
the Tang group observed involve the faster ligand exchange (compared to their bidentate 
counterparts) that was exhibited by monodentate phosphine ligands to facilitate the 
formation of a greater number of open coordination sites present on the rhodium metal 
(which favors both β-H elimination and CO deinsertion) and the use of a more electron-
deficient catalyst that exhibits stronger coordination with multisubstituted olefins that 
facilitates migratory insertion.
37
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4.3 Results and Discussion 
 
 We began our investigations with model compound 4.1a, a compound that under 
previous reaction conditions afforded fused ring product 4.2a (Scheme 4.1). 
 
  
 
 
Scheme 4.1 Previous Tri-Substituted Olefin Insertion Results. 
 
Under the initial investigations of rhodium-I precatalysts and phosphine ligands 
(Table 4.1), it was discovered that when electron-rich or bidentate ligands (such as PCy3 
or dppb), were employed, no desired decarbonylative spirocyclization product was 
obtained. More electron-deficient catalysts, on the contrary, afforded compound 4.3a in 
3% yield (entry 1). Use of an acac ligand on the rhodium in place of a chloride was found 
to be detrimental to the catalyst reactivity, leading to slight decomposition of 4.1a (entry 
2). The in situ generated cationic rhodium-I led to the dealkylation of 4.1a to give 3-OH-
benzocyclobutenone (entry 3). Use of the more electron-rich PPh3 or highly electron-
deficient phosphites as ligands completely shut down catalyst reactivity (entries 4-6). 
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Table 4.1 Selected Optimization Conditions with Compound 4.1a (a) Yields were 
determined by 1H-NMR using mesitylene as the internal standard. (b) 10 mol % 
Rh(CO)2(acac) was used. (c) 3-OH-benzocyclobutenone was isolated in 53% yield. (d) 
The reaction time was 36 h. (e) 10 mol % P(C6F5)3 ligand was used. (f) Isolated yield.  
Strikingly, the use of π -acidic triarylphosphine ligands significantly promoted 
formation of the desired spirocycle 4.3a (entries 7-11, Table 4.1), among which the 
P(C6F5)3 ligand proved to be most efficient. By simply lowering the ligand:metal ratio to 
1:1, formation of the undesired reductive-elimination product (4.2a) was significantly 
inhibited; spirocycle 4.3a was isolated as the major product in a 72% yield (entry 10). It 
is presumed that in the presence of less ligand, the rhodium metal has a larger number of 
open coordination sites for β-H elimination. 
With the optimized reaction conditions in hand, the scope of this decarbonylative 
spirocyclization was investigated (Table 4.2). Upon the examination of cyclic olefins 
with various ring sizes, it was discovered that a wide variety of ring substrates smoothly 
underwent this transformation (entries 1-5) with almost a single olefin isomer observed in 
each case. In the case of substrate 4.1e, the product afforded was a trans olefin in high 
yield likely caused by a transannular interaction introduced by the dodecacycle.38 
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Electron deficient substrates, dienes, enamides, and benzyl and vinyl ethers were all 
shown to undergo this transformation with varying success. The relatively neutral nature 
of this reaction system is believed to prevent the degradation of sensitive functionalities. 
Interestingly, with the exception of substrates 4.1a, 4.1i and 4.1m, no direct reductive 
elimination products were observed for the other substrates depicted in Table 4.2. It is 
also interesting to find that the C5-methyl-substituted benzocyclobutenone 4.1m showed 
high reactivity, whereas further substitution or functionalization at this position lead to 
sluggish product formations. 
Table 4.2 Spirocyclization Substrate Scope. (a) Reactions were run on a 0.2 mmol scale 
using 5 mol % [Rh(CO)2Cl]2 and 10 mol % P(C6F5)3, in THF, 130 oC, 36 h. (b) Isolated 
yields. (c) Ratios of olefin regioisomers were determined by 1H-NMR or based on their 
isolated yields (see supporting information for more details). (d) Numbers in the 
parenthesis are based on recovered starting material yields. (e) Compound 4.3k was 
characterized via a subsequent olefin hydrogenation (see supporting information for 
more details).  
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Further investigations not performed by the author provided mechanistic insights 
into this transformation. Following a deuterium-labeling experiment, compound 4.1n 
underwent spirocyclization to afford spirocycle 4.3n with >95% deuterium incorporation 
at the methyl substituent with an overall yield of 79% (Figure 4.4). 
 
 
Figure 4.4 Deuterium Labeling Experiment. 
 Encouraged by the success of this deuterium study, a catalytic cycle was proposed 
(Scheme 4.2) that supports the hypothesis that this transformation undergoes β-H 
elimination, decarbonylation and and reductive elimination. Unlike the cut and sew 
transformation outlined in Chapter 2, this pathway delays the direct carbon carbon 
reductive elimination to allow for the formation of spirocyclic compounds. 
 
 
 
 
 
 
 
  
46 
 
 
 
 
 
 
 
 
 
 
Scheme 4.2. Proposed Catalytic Cycle. 
Studies into internal linear olefins and greater substitutions throughout 
compounds are currently being investigated to determine potentially novel cyclization 
products and expand the scope of this reaction. 
4.4 Conclusions 
 
In conclusion, we have developed a complementary but unique method to 
generate all carbon-based spirocyclic compounds via a rhodium-catalyzed 
decarbonylative spirocyclization. In particular, this reaction operated under neutral 
reaction conditions, which suggests significant tolerance for both acid and base sensitive 
functionalization, a marked improvement on traditional spirocycle synthesis. Similarly, a 
broad substrate scope containing both electron-deficient and electron–rich compounds 
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was shown to successfully react, providing a range of structurally diverse spirocycles that 
suggests the potential for future application in natural product synthesis. Furthermore, to 
the best of our knowledge, this represents the only example of C–C activation, olefin 
insertion, β-H elimination and decarbonylation in a one-reaction sequence, methodology 
that may be investigated to unveil new tandem transformations. Further expansions of 
this project by extension of the substrate and reaction scope as well as the investigation 
into enantioselective variants are forthcoming. 
 
4.5 Experimental 
 
Preparation of Benzocyclobutenone Structures for Spirocyclization 
 
 
 
 
Compounds 4.1a and 4.2a are  
known compounds and were previously characterized by our group.39  
 
 
 
 
 
 
 
 
Following similar methods toward the synthesis of 2.1c, a flame-dried, 200 mL 
Schlenk flask equipped with a magnetic stirring bar, a nitrogen gas balloon and a 
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rubber septum was charged with S9  (3.0 g, 6.2 mmol). The flask was flushed with 
nitrogen, THF (30 mL) and S1040 (2.0 g, 9.3 mmol) were added by syringe, and the 
mixture was cooled to -78 °C with a dry ice-acetone bath. A solution of butyl-lithium in 
hexanes (2.5 M, 4.5 mL, 11.3 mmol) was added to the reaction mixture over 10 min via 
syringe. The reaction mixture was further stirred for 5 min at –78 °C, then water (5 mL) 
was added drop wise. After warming to room temperature, water (40 mL) was added, 
and the products were extracted with ethyl acetate (3 × 20 mL). The combined organic 
extract was washed with brine (40 mL), dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure to give crude product as dark brown oil. This 
was used directly for the next step without further purification. 
 
A 250-mL, three-necked, round-bottomed flask equipped with a magnetic 
stirring bar, a stopper and an nitrogen inlet was charged with the dark brown oil in 
CH3CN (100 mL), and the mixture was cooled to 0 °C in an ice-water bath. Aqueous 
HF (27.6M, 2.2 mL, 60.7 mmol) was slowly added during 2 min via syringe. The 
mixture was warmed to 40oC, then stirred overnight. The reaction mixture was 
carefully poured into saturated aqueous sodium bicarbonate solution (60 mL), and the 
products were extracted with ethyl acetate (3 × 30 mL). The combined organic extract 
was successively washed with saturated aqueous sodium bicarbonate solution (30 mL) 
and brine (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure to give a yellow oil residue. The residue was purified by 
column chromatography on silica gel to give 213.3 mg (21% over two steps) of S11 as 
  
49 
viscous oil. Rf=0.25 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.42 (dd, J = 
8.4, 6.8 Hz, 1H), 7.02 (d, J = 7.2 Hz, 1H), 6.82 (d, J = 5.6 Hz, 1H), 6.72-6.68 (m, 1H), 
4.99-4.96 (m, 2H), 3.90 (s, 2H). 
13
C NMR (101 MHz, CDCl3):  189.6, 155.6, 150.1, 
139.2, 132.7, 118.3, 115.6 92.1, 57.0. IR: v 2960, 1735, 1612, 1453, 1302, 1147, 1051, 
853 cm-1; HRMS calc’d. for C9H8O3Na+ [M+Na]+: 187.0366. Found: 187.0371. 
 
General Procedure I for the Synthesis of 4.1b, 4.1c, 4.1d, 4.1e, 4.1h, 4.1i, 4.1j, 4.1l, 
4.1m and 4.1n 
 
A flame-dried Schlenk flask equipped with a magnetic stirrer bar was charged 
with 6-hydroxybenzocyclobutanone (1.0 equiv.), PPh3 (1.0 equiv.), allyl alcohol (1.0 
equiv.) and the flask was degassed three times under nitrogen before THF was added 
via cannula. Then DIAD (1.0 equiv.) was added drop wise via syringe to the above 
solution and the reaction was heated to reflux. TLC was used to monitor the reaction 
(completion usually occurred within 3 h). When the reaction was finished, it was 
concentrated under reduced pressure and the residue was purified by column 
chromatography on silica gel to afford the desired product. 
 
 
 
 
4.1b was synthesized from the known compound S1241 (98 mg, 1.0 mmol) and the 
known 6-hydroxybenzocyclobutanone (134 mg, 1.0 mmol) following general procedure 
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I and was isolated as a light yellow oil (189.7 mg) in 89% yield. RF=0.55 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3):  7.41 (dd, J = 8.4, 7.2 Hz, 1H), 
7.00 (d, J = 7.2 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 5.74 (m, 1H), 4.96 (s, 2H), 3.89 (s, 
2H), 2.41~2.32 (m, 4H), 1.96~1.87 (m, 2H). 13C NMR (100 MHz, CDCl3):  185.0, 
152.6, 150.6, 139.6, 137.7, 132.5, 28.8, 116.3, 115.0, 71.2, 51.2, 32.8, 32.5, 23.3. IR: v 
1761, 1603, 1573, 1274, 1158, 1128, 1052, 782 cm-1; HRMS calc’d. for C14H15O2+ 
[M+H]+: 215.1072. Found: 215.1069. 
 
 
 
 
 
 
4.1c was synthesized from the known compound S1342 (295 mg, 2.2 mmol) following 
general procedure I and was isolated as a colorless sticky oil (371.7 mg) in 71% yield. 
RF=0.60 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.42 (dd, J = 8.4, 6.8 Hz, 
1H), 7.01 (d, J = 6.8 Hz, 1H), 6.83 (d, J = 8.4 Hz, 1H), 5.96 (m, 1H), 4.76 (s, 2H), 3.90 
(s, 2H), 2.24-2.20 (m, 2H), 2.18-2.01 (m, 2H), 1.79-1.71 (m, 2H), 1.58-1.46 (m, 4H). 
13
C NMR (101 MHz, CDCl3):  185.1, 152.8, 150.6, 139.6, 137.7, 132.6, 131.1, 116.5, 
115.0, 78.0, 51.2, 32.4, 30.3, 28.4, 27.0, 26.7. IR: v 1770, 1602, 1574, 1456, 1278, 
1054, 781 cm-1; HRMS calc’d. for C16H18O2Na+ [M+Na]+: 265.1199. Found: 265.1199. 
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4.1d was synthesized from the known compound S1443 (123.1 mg, 1.0 mmol) following 
general procedure I and was isolated as a colorless oil (170 mg) in 66% yield. Rf=0.60 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.42 (dd, J = 8.4, 7.6 Hz, 1H), 
7.00 (d, J = 7.6 Hz, 1H), 6.83 (d, J = 8.4 Hz, 1H), 5.80 (m, 1H), 4.82 (s, 2H), 3.91 (s, 
2H), 2.30-2.26 (m, 2H), 2.19-2.13 (m, 2H), 1.62-1.48 (m, 8H). 
13
C NMR (101 MHz, 
CDCl3):  185.1, 152.7, 150.6, 137.7, 136.2, 132.6, 129.4, 116.5, 114.95, 76.6, 51.2, 
29.5, 28.9, 26.82, 26.40, 26.35, 26.11. IR: v 1767, 1602, 1572, 1472, 1275, 1049, 974, 
782 cm-1; HRMS calc’d. for C17H19O2- [M-H]-: 255.1385. Found: 255.1385. 
 
 
 
 
 
 
 
 
4.1e was synthesized from the known compound S1544 (196.2 mg, 1.0 mmol) following 
the general procedure I and was isolated as a clear oil (280 mg) in 90% yield. Rf=0.65 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.42 (dd, J = 8.4, 7.6 Hz, 1H), 
7.02 (d, J = 7.6 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 5.70 (t, J = 8.0 Hz, 1H), 4.96 (s, 2H), 
3.93 (s, 2H), 2.30-2.24 (m, 2H), 2.23-2.16 (m, 2H), 1.62-1.28 (m, 16H). 
13
C NMR (101 
MHz, CDCl3):  185.1, 152.9, 150.7, 137.7, 134.4, 132.89, 132.72, 116.4, 115.1, 69.6, 
51.3, 34.2, 28.0, 26.90, 26.84, 25.92, 25.78, 24.47, 24.45, 23.75. IR: v 2857, 1770, 
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1604, 1572, 1472, 1273, 1128, 1049, 979, 782 cm-1; HRMS calc’d. for C21H28O2+ [M]+: 
312.2089. Found: 312.2089. 
 
 
 
 
 
 
 
4.1h was synthesized from the known compound S1645 (273 mg, 2.2 mmol) following 
general procedure I and was isolated as a white solid (371.7 mg) in 71% yield. Rf=0.65 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.46 (dd, J = 8.4, 7.2 Hz, 1H), 
7.28-7.25 (m, 1H), 7.17-7.13 (m, 1H), 7.07 (d, J = 7.2 Hz, 1H), 6.95-6.90 (m, 1H), 6.88 
(d, J = 8.4 Hz, 1H), 6.84-6.81 (m, 1H), 5.98 (m, 1H), 5.25 (m, 2H), 4.84 (m, 2H), 3.97 
(s, 2H). 
13
C NMR (101 MHz, CDCl3):  185.2, 154.2, 152.0, 150.7, 138.0, 132.6, 
129.70, 129.54, 123.7, 121.53, 121.45, 120.78, 116.56, 116.13, 115.66, 71.2, 65.3, 
51.4. IR: v 1760, 1603, 1574, 1273, 1222, 1129, 756 cm-1; HRMS calc’d. for 
C18H14O3Na+ [M+Na]+: 301.0835. Found: 301.0831. Mp. 65-67 oC 
 
 
 
 
 
 
4.1i was synthesized from the known compound S1746 (73.7 mg, 0.276 mmol) 
following general procedure I and was isolated as a white solid (102.8 mg) in 97% 
yield. Rf=0.25 (EtOAc/Hexane=1/3). 1H NMR (400 MHz, CDCl3): 7.67 (d, J = 6.8 
Hz, 2H), 7.44 (dd, J = 8.4, 7.2 Hz, 1H), 7.30 (d, J = 6.8 Hz, 2H), 7.04 (d, J = 7.2 Hz, 
  
53 
1H), 6.82 (d, J = 8.4 Hz, 1H), 5.91 (m, 1H), 4.78 (s, 2H), 3.91 (s, 2H), 3.68 (m, 2H), 
3.17 (t, J = 6.0 Hz, 2H), 2.43 (s, 3H), 2.25-2.23 (m, 2H). 
13
C NMR (101 MHz, CDCl3): 
 185.2, 152.0, 150.6, 143.7, 138.0, 133.5, 132.4, 130.2, 129.8, 127.8, 124.9, 116.6, 
115.6, 74.0, 51.3, 45.4, 42.5, 25.1, 21.7. IR: v 1760, 1603, 1475, 1339, 1271, 1095, 
784, 663 cm-1; HRMS calc’d. for C21H21NO4SNa+ [M+Na]+: 406.1083. Found: 
406.1097. Mp. 80-85 oC 
 
 
 
 
 
 
 
4.1j was synthesized from S11 and the known compound S12 (98 mg, 1.0 mmol) 
following general procedure I and was isolated as a viscous oil (200.5 mg) in 83% 
yield. Rf=0.50 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.51 (dd, J = 8.4, 
7.2 Hz, 1H), 7.22 (d, J = 7.2 Hz, 1H), 6.97 (d, J = 8.4 Hz, 1H), 5.77-5.72 (m, 1H), 5.50 
(s, 1H), 5.05-4.92 (m, 2H), 3.53 (s, 3H), 2.44-2.30 (m, 4H), 1.97-1.87 (m, 2H). 
13
C 
NMR (101 MHz, CDCl3):  186.32, 155.06, 153.56, 139.41, 138.30, 132.57, 129.06, 
118.45, 115.50, 91.94, 71.41, 56.84, 32.83, 32.58, 23.39. IR: v 1772, 1604, 1574, 1472, 
1273, 1128, 1049, 782 cm-1; HRMS calc’d. for C15H16O3Na+ [M+Na]+: 267.0992. 
Found: 267.1000. 
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4.1l was synthesized from the known compound S1847 (126.2 mg, 1.0 mmol) following 
the general procedure-I and was isolated as a colorless oil (225 mg) in 94% yield. 
Rf=0.75 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3):  7.40 (dd, J = 8.4, 7.2 
Hz, 1H), 6.99 (d, J = 7.2 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 5.67 (t, J = 6.4 Hz, 1H), 
4.42 (t, J = 6.4 Hz, 2H), 3.89 (s, 2H), 2.46-2.42 (m, 2H), 2.20-2.16 (m, 2H), 2.11-2.06 
(m, 2H), 1.76-1.69 (m, 2H), 1.52-1.43 (m, 4H). 
13
C NMR (101 MHz, CDCl3):  185.0, 
152.8, 150.6, 140.6, 137.7, 132.5, 128.7, 116.3, 114.9, 71.4, 51.2, 39.8, 32.96, 32.70, 
28.5, 27.3, 26.7. IR: v 1770, 1603, 1572, 1475, 1275, 1052, 782 cm-1; HRMS calc’d. 
for C17H20O2+ [M]+: 256.1463. Found: 256.1460. 
 
 
General Procedure II for the Synthesis of 4.1f, 4.1g, and 4.1k 
 
Allyl halide (1.25 equiv.) was added in one portion to a solution of acetone 
containing 6-hydroxybenzocyclobutanone (1 equiv.), K2CO3 (5 equiv.) and KI (2 
equiv.). The reaction mixture was heated to reflux and stirred overnight. Then the 
reaction was quenched with aqueous ammonium chloride. The aqueous phase was 
extracted with ethyl acetate and the combined organic extract was washed with brine, 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure 
to give a residue that was purified by column chromatography on silica gel. 
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4.1f was synthesized from the known compound S2048 (350 mg, 2 mmol) following 
general procedure II and was isolated as a white solid (180 mg) in 39% yield. Rf=0.20 
(EtOAc/Hexane=1/3). 1H NMR (400 MHz, CDCl3): 7.66 (m, 1H), 7.42 (dd, J = 8.4, 
7.2 Hz, 1H), 7.04 (d, J = 7.2 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 5.07 (m, 2H), 3.91 (s, 
2H), 2.67-2.62 (m, 2H), 2.50-2.40 (m, 2H). 
13
C NMR (101 MHz, CDCl3):  207.9, 
184.8, 161.3, 152.0, 150.7, 141.6, 137.9, 132.5, 116.2, 115.6, 65.7, 51.4, 34.9, 27.1. IR: 
v 1760, 1699, 1601, 1574, 1472, 1274, 784 cm-1; HRMS calc’d. for C14H12O3Na+ 
[M+Na]+: 251.0679. Found: 251.0677. Mp. 68-70 oC 
 
 
 
 
 
 
 
4.1g was synthesized from the known compound S2149 (156.7 mg, 1 mmol) following 
general procedure II and was isolated as a colorless oil (124.2 mg) in 61% yield. 
Rf=0.65 (EtOAc/Hexane=1/3). 1H NMR (400 MHz, CDCl3): 7.42 (dd, J = 8.0, 7.2 
Hz, 1H), 7.01 (d, J = 7.2 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 5.83 (m, 1H), 4.82 (s, 2H), 
3.91 (s, 2H), 2.70-2.60 (m, 4H), 1.67 (s, 3H), 1.64 (s, 3H).  
13
C NMR (101 MHz, 
CDCl3):  185.2, 152.7, 150.7, 137.8, 132.6, 131.1, 124.0, 122.85, 122.78, 116.5, 115.1, 
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76.0, 51.3, 33.61, 33.58, 18.64, 18.38. IR: v 1760, 1699, 1601, 1574, 1472, 1274, 784 
cm-1.  HRMS calc’d. for C17H18O2Na+ [M+Na]+: 277.1199. Found: 277.1202. 
 
 
 
 
 
 
 
4.1k was synthesized from S22 (43.8 mg, 0.23 mmol) and the known compound S2350 
(47 mg, 0.40 mmol) following general procedure II and was isolated as a colorless oil 
(50 mg) in 81% yield. Rf=0.40 (EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 
7.45-7.39 (m, 2H), 7.32 (m, 1H), 5.30 (s, 1H), 4.03 (t, J = 8.0 Hz, 1H), 3.96 (s, 2H), 
3.66 (s, 3H), 2.99-2.92 (m, 1H), 2.77-2.70 (m, 1H), 2.22-2.18 (m, 4H), 1.82-1.73 (m, 
2H). 
13
C NMR (101 MHz, CDCl3):  187.8, 173.2, 151.4, 146.5, 141.1, 135.4, 134.8, 
128.1, 126.2, 122.5, 52.4, 52.2, 47.5, 35.1, 34.1, 32.6, 23.5. IR: v 1602, 1425, 1332, 
1261, 1025, 783 cm-1; HRMS calc’d. for C17H19O3+ [M+H]+: 271.1329. Found: 
271.1334. 
 
 
General Procedure for the Rh-catalyzed Decarbonylative Spirocyclization 
(Reaction was performed at 0.2 mmol scale and 0.1 M concentration): 
 
In a nitrogen filled glove box, a 1 dram vial was charged with 5 mol % 
[Rh(CO)2Cl]2 and 10 mol % P(C6F5)3. A solution of the starting material in THF (2 mL) 
was added and the 1 dram vial was capped and the solution was maintained at 130 °C 
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for 36 h. The reaction was removed from the glove box, concentrated and purified by 
flash chromatography. 
 
 
 
 
4.3a was isolated as a colorless crystal (33.6 mg) in 72% yield. Rf=0.75 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.04 (dd, J = 7.6, 7.6 Hz, 1H), 
6.66 (d, J = 7.2 Hz, 1H), 6.65 (d, J = 7.2 Hz, 1H), 5.83-5.76 (m, 1H), 5.73-5.66 (m, 
1H), 4.33 (d, J = 8.4 Hz, 1H), 4.22 (d, J = 8.4 Hz, 1H), 2.60-2.50 (m, 1H), 2.40-2.30 
(m, 4H), 2.25-2.05 (m, 3H), 1.80-1.70 (m, 1H). 
13
C NMR (101 MHz, CDCl3):  
160.07, 134.83, 132.07, 128.27, 127.36, 125.33, 123.46, 107.78, 81.31, 45.75, 34.27, 
29.97, 22.78, 18.62. IR: v 1590, 1461, 1232, 1021, 996, 783 cm-1; HRMS calc’d. for 
C14H16O+ [M]+: 200.1201. Found: 200.1201. Mp. 35-40 oC. 
 
  
 
 
 
 
 
4.3b and 4.3b’ were obtained as an inseparable mixture (33.5 mg) in a combined 78% 
yield. Rf=0.75 (EtOAc/Hexane=1/5). 4.3b 1H NMR (400 MHz, CDCl3): 7.05 (dd, J = 
8.0, 7.6 Hz, 1H), 6.71-6.64 (m, 2H), 5.80-5.74 (m, 2H), 4.42 (s, 2H), 3.03-2.94 (m, 
2H), 2.64-2.57 (m, 2H), 2.26 (s, 3H). 4.3b’ 1H NMR (400 MHz, CDCl3):  7.05 (dd, J 
= 8.0, 7.6 Hz, 1H), 6.71-6.64 (m, 2H), 5.91 (dt, J = 5.6, 2.47 Hz, 1H), 5.70 (dt, J = 5.6, 
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2.4 Hz, 1H), 4.32 (d, J = 8.4 Hz, 1H), 4.23 (d, J = 8.8 Hz, 1H), 2.57-2.52 (m, 2H), 2.24 
(s, 3H), 2.22-2.15 (m, 2H). 4.3b & 4.3b’ 13C NMR (101 MHz, CDCl3):  159.99, 
159.82, 135.50, 134.795, 134.14, 132.54, 132.28, 129.34, 128.38, 128.12, 123.33, 
123.16, 107.37, 107.32, 88.08, 81.87, 59.34, 51.04, 46.75, 36.58, 32.10, 18.19, 17.43. 
IR: v 2001, 1591, 1518, 1483, 1248, 1092, 985, 776 cm-1; HRMS calc’d. for C13H14O+ 
[M]+: 186.1045. Found: 186.1047. 
 
 
 
 
4.3c was isolated as a colorless oil (41.4 mg) in 86% yield. Rf=0.70 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.01 (dd, J = 7.6, 7.6 Hz, 1H), 
6.63 (d, J = 7.6 Hz, 2H), 6.65 (d, J = 7.2 Hz, 1H), 5.96 (m, 1H), 5.77 (m, 1H), 4.34-
4.24 (m, 2H), 3.01-2.93 (m, 1H), 2.41 (s, 3H), 3.60-2.15 (m, 4H), 2.08-2.01 (m, 1H), 
1.79 (m, 1H), 1.47 (m,1H). 
13
C NMR (101 MHz, CDCl3):  159.23, 134.46, 134.42, 
134.14, 128.21, 128.02, 123.44, 107.81, 79.12, 48.64, 39.78, 36.20, 28.90, 23.54, 
19.09. IR: v 1588, 1461, 1247, 1028, 988, 774, 737 cm-1; HRMS calc’d. for C15H18O+ 
[M]+: 214.1358. Found: 214.1358. 
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4.3d was isolated as a colorless oil (25.6 mg) in 56% yield. Rf=0.75 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.01 (dd, J = 7.6, 7.6 Hz, 1H), 
6.66-6.61 (m, 2H), 5.84-5.69 (m, 2H), 4.40-4.24 (m, 2H), 2.92-2.84 (m, 1H), 2.42 (s, 
3H), 2.30-2.22 (m, 1H), 2.16-2.05 (m, 2H), 1.92-1.83 (m, 1H), 1.70-1.58 (m, 4H), 1.44-
1.38 (m, 1H). 
13
C NMR (101 MHz, CDCl3):  159.3, 134.43, 134.32, 132.6, 127.95, 
127.76, 123.5, 107.9, 80.3, 52.1, 35.2, 34.7, 28.4, 24.7, 21.2, 19.5. IR: v 1587, 1466, 
1245, 1231, 988, 773, 732 cm-1; HRMS calc’d. for C16H20O+ [M]+: 228.1514. Found: 
228.1517. 
 
 
  
 
4.3e was isolated as a colorless oil (51.2 mg) in 90% yield. Rf=0.80 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.02 (dd, J = 8.0, 8.0 Hz, 1H), 
6.68-6.62 (m, 2H), 5.82 (d, J = 16.0 Hz, 1H), 5.51-5.43 (m, 1H), 4.58 (d, J = 8.8 Hz, 
1H), 4.24 (d, J = 8.8 Hz, 1H), 2.42 (s, 3H), 2.29-2.20 (m, 1H), 2.06-1.81 (m, 3H), 1.66-
1.22 (m, 14H). 
13
C NMR (101 MHz, CDCl3):  159.3, 134.5, 132.09, 132.00, 129.2, 
128.1, 123.5, 107.9, 78.5, 53.1, 35.9, 31.8, 26.8, 25.74, 25.04, 24.48, 24.33, 24.25, 
21.91, 19.3. IR: v 1588, 1463, 1250, 1077, 993, 773, 738 cm-1; HRMS calc’d. for 
C20H28O+ [M]+: 284.2140. Found: 284.2139. 
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4.3f was isolated as a colorless oil (11.2 mg) in 29% yield. Rf=0.30 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.84 (dt, J = 5.6, 2.8 Hz, 1H), 
7.08 (dd, J = 8.0, 7.6 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 6.65 (d, J = 7.6 Hz, 1H), 6.04 
(dt, J = 5.6, 2.4 Hz, 1H), 4.57 (d, J = 8.8 Hz, 1H), 4.38 (d, J = 8.8 Hz, 1H), 3.16-3.03 
(m, 2H), 2.00 (s, 3H). 
13
C NMR (101 MHz, CDCl3):  209.79, 163.05, 160.96, 134.40, 
134.02, 129.48, 128.12, 123.15, 107.77, 82.20, 57.37, 45.29, 18.31. IR: v 1750, 1597, 
1420, 1223, 775, 712 cm-1; HRMS calc’d. for C13H12O2+ [M]+: 200.0837. Found: 
200.0838.  
 
4.3f’ was isolated as a colorless oil (8.0 mg) in 21% yield. Rf=0.45 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.08 (dd, J = 8.0, 7.6 Hz, 1H), 
6.70 (d, J = 8.0 Hz, 1H), 6.63 (d, J = 7.6 Hz, 1H), 6.29 (dt, J = 7.2, 2.4 Hz, 1H), 6.15 
(dt, J = 7.2, 2.4 Hz, 1H), 4.55 (d, J = 8.8 Hz, 1H), 4.36 (d, J = 8.8 Hz, 1H), 3.20-3.02 
(m, 2H), 2.08 (s, 3H). 
13
C NMR (101 MHz, CDCl3):  216.72, 160.96, 135.31, 134.23, 
129.78, 128.04, 124.01, 123.01, 107.87, 78.91, 72.45, 63.78, 42.32, 25.39, 17.68, 
5.397. IR: v 1749, 1587, 1470, 1251, 986, 774, 715 cm-1; HRMS calc’d. for C13H13O2+ 
[M+H]+: 201.0916. Found: 201.0916. 
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4.3g and 4.3g’ were obtained as an inseparable mixture (29.4 mg) in a combined 65% 
yield. Rf=0.75 (EtOAc/Hexane=1/5). 4.3g 1H NMR (400 MHz, CDCl3): 7.05 (dd, J = 
8.0, 8.0 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 6.65 (d, J = 8.0 Hz, 1H), 5.89 (d, J = 9.2 Hz, 
1H), 5.66 (d, J = 9.2 Hz, 1H), 4.48 (d, J = 8.8 Hz, 1H), 3.96 (d, J = 8.8 Hz, 1H), 2.65-
2.57 (m, 1H), 2.27-2.20 (m, 1H), 2.34 (s, 3H), 1.76 (s, 3H), 1.73 (s, 3H). 4.3g’ 1H 
NMR (400 MHz, CDCl3): 7.03 (dd, J = 8.0, 8.0 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 
6.64 (d, J = 8.0 Hz, 1H), 5.55 (m, 1H), 5.50 (brs, 1H), 4.57 (d, J = 8.8 Hz, 1H), 3.92 (d, 
J = 8.8 Hz, 1H), 2.57-2.50 (m, 1H), 2.36 (s, 3H), 2.35-2.27 (m, 1H), 1.85 (s, 3H), 1.82 
(s, 3H). 4.3g & 4.3g’ 13C NMR (101 MHz, CDCl3):  159.7, 135.39, 135.32, 134.4, 
133.34, 132.99, 132.75, 130.5, 128.44, 128.32, 127.02, 126.31, 125.91, 123.68, 123.32, 
123.26, 120.5, 107.4, 79.71, 79.21, 47.28, 46.96, 40.2, 33.7, 20.05, 19.64, 19.48, 19.32, 
19.15, 17.4. IR: v 1591, 1470, 1468, 1247, 1215, 981, 774, 745 cm-1; HRMS calc’d. 
for C16H18O+ [M]+: 226.1358. Found: 226.1356. 
 
 
 
4.3h was isolated as a colorless oil (35.5 mg) in 71% yield. Rf=0.85 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.20-7.14 (m, 1H), 7.11 (dd, J = 
8.0, 7.6 Hz, 1H), 7.02-6.97 (m, 2H), 6.96-6.92 (m, 1H), 6.75 (d, J = 8.0 Hz, 1H), 6.67 
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(d, J = 6.0 Hz, 1H), 6.64 (m, 1H), 4.98 (d, J = 7.2 Hz, 1H), 4.64 (d, J = 8.8 Hz, 1H), 
4.47 (d, J = 8.8 Hz, 1H), 2.01 (s, 3H). 
13
C NMR (101 MHz, CDCl3):  159.1, 149.8, 
139.7, 136.4, 132.0, 129.31, 128.56, 128.24, 125.0, 124.4, 123.6, 116.2, 107.6, 105.3, 
87.7, 45.5, 17.4. IR: v 2004, 1665, 1485, 1452, 1247, 1051, 983, 757 cm-1; HRMS 
calc’d. for C17H15O2+ [M+H]+: 251.1072. Found: 251.1071. 
 
 
  
 
4.3i was isolated as a colorless oil (36.3 mg) in 53% yield. Rf=0.30 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.64 (m, 2H), 7.31 (m, 2H), 7.09 
(dd, J = 8.0, 7.6 Hz, 1H), 6.69 (d, J = 7.6 Hz, 1H), 6.62 (d, J = 8.0 Hz, 1H), 5.90 (m, 
2H), 4.70 (d, J = 9.2 Hz, 1H), 4.16-4.05 (m, 2H), 3.80-3.74 (m, 1H), 3.21-3.15 (m, 1H), 
2.52-2.47 (m, 1H), 2.43 (s, 3H), 2.13 (m, 3H). 
13
C NMR (101 MHz, CDCl3):  160.9, 
144.0, 135.5, 133.3, 129.95, 129.60, 129.46, 127.75, 127.45, 124.6, 123.0, 108.1, 78.7, 
49.2, 48.7, 44.6, 21.7, 17.8. IR: v 1645, 1589, 1486, 1346, 1165, 1092, 776, 665 cm-1; 
HRMS calc’d. for C20H21NO3SNa+ [M+Na]+: 378.11340. Found: 378.11470.  
 
4.3i’ was isolated as a colorless oil (11.3 mg) in 16% yield. Rf=0.35 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 7.68 (m, 2H), 7.34 (m, 2H), 7.06 
(dd, J = 8.0, 7.6 Hz, 1H), 6.79 (m, 1H), 6.67-6.61 (m, 2H), 4.94 (m, 1H), 4.12-4.02 (m, 
2H), 3.80-3.75 (m, 1H), 3.39-3.34 (m, 1H), 2.62-2.55 (m, 1H), 2.45 (s, 3H), 2.21 (s, 
3H), 2.09-2.01 (m, 1H). 
13
C NMR (101 MHz, CDCl3):  160.6, 144.2, 135.21, 134.73, 
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130.1, 129.4, 127.8, 127.1, 125.4, 123.6, 108.2, 104.4, 80.9, 49.2, 45.3, 31.2, 21.8, 
18.4. IR: v 1519, 1484, 1392, 1266, 1092, 1052, 984, 741 cm-1; HRMS calc’d. for 
C20H21NO3SNa+ [M+Na]+: 378.1134. Found: 378.1147. 
 
The direct reductive elimination product 2i was isolated as a white solid (10.0 mg) in 
14% yield. Rf=0.25 (EtOAc/Hexane=1/3). 1H NMR (400 MHz, CDCl3): 7.54 (m, 
2H), 7.27 (m, 2H), 7.18 (dd, J = 8.0, 7.6 Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 6.67 (d, J = 
7.6 Hz, 1H), 5.09 (d, J = 8.8 Hz, 1H), 4.27 (dd, J = 8.8, 2.4 Hz, 1H), 3.85-3.80 (m, 1H), 
3.77-3.71 (m, 1H), 3.55-3.40 (m, 2H), 2.57-2.51 (m, 2H), 2.41 (s, 3H), 2.45-2.17 (m, 
1H), 1.92 (dd, J = 11.6, 2.4 Hz, 1H), 1.76-1.66 (m, 1H). 
13
C NMR (101 MHz, CDCl3): 
 1-208.5, 159.3, 144.0, 133.0, 130.78, 130.76, 130.0, 127.6, 127.2, 119.4, 108.7, 81.8, 
50.44, 50.31, 45.6, 43.1, 40.8, 22.5, 21.7. IR: v 1706, 1645, 1471, 1338, 1164, 1105, 
961, 756 cm-1; HRMS calc’d. for C21H21NO4SNa+ [M+Na]+: 406.1083. Found: 
406.1097. 
 
  
 
4.3j was isolated as a colorless oil (25.5 mg) in 59% yield. Rf=0.55 
(EtOAc/Hexane=1/5).  1H NMR (400 MHz, CDCl3): 7.15 (dd, J = 8.0, 7.6 Hz, 1H), 
6.93 (d, J = 8.0 Hz, 1H), 6.75 (d, J = 7.6 Hz, 1H), 5.93 (m, 1H), 5.73 (m, 1H), 4.50-
4.15 (m, 4H), 3.37 (s, H), 2.53 (m, 2H), 2.25-2.19 (m, 2H). 
13
C NMR (101 MHz, 
CDCl3):  160.2, 135.5, 134.1, 132.8, 131.5, 128.7, 121.4, 109.3, 81.8, 70.4, 59.4, 58.3, 
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37.8, 32.0. IR: v 1590, 1519, 1480, 1248, 1092, 986, 773 cm-1; HRMS calc’d. for 
C14H16O2+ [M]+: 216.1150. Found: 216.1151. 
 
  
4.3k was isolated after subsequent hydrogenation (with 10% Pd/C under 1atm H2) as 
colorless oil (27.8 mg) in 57% yield (over two steps). Rf=0.35 (EtOAc/Hexane=1/5). 
1H NMR (400 MHz, CDCl3): 7.16 (d, J = 7.6 Hz, 1H), 7.10 (dd, J = 7.6, 7.6 Hz, 1H), 
7.02 (m, 1H), 3.99 (t, J = 8.0 Hz, 1H), 3.75 (s, 3H), 2.37 (s, 3H), 2.31-2.24 (m, 3H), 
1.92-1.64 (m, 8H). 
13
C NMR (101 MHz, CDCl3):  174.9, 147.6, 140.8, 133.9, 130.9, 
126.8, 122.5, 55.3, 52.2, 48.2, 45.8, 38.61, 38.3, 26.1, 19.2. IR: v 1740, 1504, 1466, 
1168, 971, 765 cm-1; HRMS calc’d. for C16H20O2Na+ [M+Na]+: 267.1356. Found: 
267.1356. 
 
  
 
4.3l was isolated as a colorless oil (36.1 mg) in 79% yield. Rf=0.80 
(EtOAc/Hexane=1/5). 1H NMR (400 MHz, CDCl3): 6.98 (dd, J = 8.0, 7.6 Hz, 1H), 
6.73-6.66 (m, 2H), 5.92-5.84 (m, 1H), 5.69-5.62 (m, 1H), 4.15-4.02 (m, 2H), 3.45-3.36 
(m, 1H), 2.59 (s, 3H), 2.52-2.42 (m, 1H), 2.38-1.58 (m, 8H). 
13
C NMR (101 MHz, 
CDCl3):  154.7, 137.6, 132.5, 131.3, 128.4, 126.8, 125.3, 115.9, 62.1, 39.98, 37.15, 
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37.06, 34.1, 29.4, 23.9, 22.5. IR: v 1580, 1463, 1257, 1030, 775, 737 cm-1; HRMS 
calc’d. for C16H20O+ [M]+: 228.1514. Found: 228.151. 
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Chapter 5: Benzocyclobutenone Derivative Synthesis 
(With Mr. Penghao Chen) 
 
5.1 Introduction 
 
The development of novel synthetic methodologies toward accessing a library of 
derivatized compounds is of significant importance in the field of organic synthesis. 
Although previous work has outlined the use of rhodium-mediated chemistry to access a 
variety of fused functionalized ring systems, two equally challenging problems remain 
unsolved regarding this methodology. One is the reliable, large-scale production of 
substrate percursors capable of cyclization and the other is the early-stage 
functionalization to afford a diverse array of products. Recently, Wu and coworkers 
discovered a multicomponent one-pot coupling to afford a variety of bicyclic and 
tetracyclic ring systems (Scheme 5.1)51 
 
 
Scheme 5.1 One-pot Benzocyclobutenol Synthesis  
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Their chemistry was found to be tolerant of a variety of substrates and by using a 
cyclic imine precursor, the core structure of berbine derivatives were rapidly constructed. 
Utilizing benzyne chemistry shares a similar structural scaffold to the desired precursors 
for our rhodium chemistry and was thusly investigated toward a library synthesis of 
substrates.  
 
5.2 Research Objectives 
 
 In this chapter, we aim to synthesize benzocyclobutenone derivatives through a 
benzyne mediated key step, followed by a simple oxidation and (if necessary) 
deprotection. Rather than further functionalize the intermediates outlined in Scheme 5.1 
by introducing dieneophiles, we instead propose their isolation. Key to our success is the 
use of readily available chemical precursors and the elimination of long synthetic 
sequences that plagued previous efforts toward benzocyclobuenone synthesis. A variety 
of substrates have been examined and optimized conditions have been discovered 
outlining a three step sequence to functionalized products. 
 
5.3 Results and Discussion 
 
 The early investigations into this portion of work studied the reactivity 
halobenzene compounds (whose syntheses are outlined in later supplemental 
information) in benzyne-mediated reactions. Scheme 5.2 highlights the general scope of 
the transformation, utilizing a ring-opened tetrahydrofuran as the enol coupling partner 
for the [2+2] cyclization. 
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Scheme 5.2 Benzocyclobutenone Synthesis 
 
 Although simple halobenzenes were found incapable of affording desired 
products (regardless of substitution pattern and number of halogens present), it was 
discovered that halogen (-Cl, -Br, -I) substitution at both the –ortho or –meta positions to 
a phenolic oxygen underwent this transformation smoothly in moderate yields (Table 
5.1). Although free phenol and silyl-protected alcohols did not afford any desired 
product, the use of benzyl as a protecting group afforded benzocyclobutanols in modest 
yields. Similarly, the conversion of phenol into an alkyl phenyl ether afforded products 
capable of cyclization whose functionalities remained intact. Poly-substitution on the 
phenyl backbone inhibited reactivity, except in the case of a methyl substituent in 
substrate 5.6a.  Further derivatization of the heteroatom linkage at this time has proven 
unsuccessful.  
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Table 5.1 Substrate Scope for [2+2] Cyclization 
  
 Although detailed in later supplemental information, it is important to note that 
these [2+2] intermediates were capable of facile oxidation to the desired “cut and sew” 
chemistry precursors under a variety of oxidative conditions. In situations containing 
benzyl-protected compounds, a unique deprotection was developed and implemented, as 
traditional debenzylation conditions were discovered to destroy the cyclobutanone ring. 
 
5.4 Conclusions 
 
 The synthesis of benzocyclobutenone derivatives was achieved in synthetically 
fewer steps than our previous investigations. A pendant heteroatom linkage allowed for 
further functionalization and proved tolerant of the reaction conditions. Further 
experimentation (most notably, the expansion of the substrate scope) is currently in 
progress. Future applications to a class of natural products, as well as expansions of 
olefinic coupling partners and phenyl precursors are all viable expansions of this 
methodology.  
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5.5 Experimental  
 
Benzyl protected phenols 5.1a-5.4a are commercially available compounds. 
 
Synthesis of 5.5a 
 
A flame-dried, 40 mL sealed vial equipped with a magnetic stirring bar was 
charged with 3-bromophenol (1.72 g, 1 mmol), K2CO3 (1.72 g, 1.2 mmol), 3-chloro-2-
methyl-propene (1.72 g, 1.2 mmol) and a catalytic amount of KI.  The vial was flushed 
with nitrogen, acetone (20 mL) was added by syringe, and the mixture was heated to 
reflux with a pi-block and allowed to stir overnight. Upon completion by TLC, the flask 
was cooled to room temperature water (20 mL) was added, and the products were 
extracted with ethyl acetate (3 × 20 mL). The combined organic extract was washed 
with brine (40 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure to give crude product as a yellow oil. This was used directly for 
the next step without further purification. 
 
5.5a Rf=0.56 (EtOAc/Hexane=1/5).  1H NMR (400 MHz, CDCl3): 7.11 (m, 3H), 6.84 
(dq, J = 4.0 Hz, 1H), 5.06 (d, J = 8.0 Hz, 2H), 4.39 (s, 2H), 1.81 (s, 3H). 13C NMR 
(101 MHz, CDCl3):  160, 140, 130, 124, 123, 120, 119, 113, 72, 19  
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Synthesis of Benzocyclobutanols 
 
 
 
 
 
A flame-dried, 50 mL Schlenk flask equipped with a magnetic stirring bar, a 
nitrogen gas balloon and a rubber septum was charged with THF (12 mL) and cooled to 
0 °C with an ice bath. A solution of butyl-lithium in hexanes (2.5 M, 1 mL, 2.5 mmol) 
was added to the reaction mixture over 10 min via syringe. The reaction mixture was 
further stirred for 16 hours at room temperature.  
A flame-dried, 25 mL Schlenk flask equipped with a magnetic stirring bar, a 
nitrogen gas balloon and a rubber septum was charged with THF (5 mL) and TMP 
(1.06 mL, 6.25 mmol) and cooled to 0 °C with an ice bath. A solution of butyl-lithium 
in hexanes (2.5 M, 2.5 mL, 6.25 mmol) was added to the reaction mixture over 10 min 
via syringe. The reaction mixture was further stirred for 30 minutes.   
The 50 mL Schlenk flask was further cooled to -78 °C using a dry ice-acetone 
bath. To this flask was added the LiTMP solution (outlined above) and 1.0 mmol of the 
desired substrate. This flask was allowed to stir cold and monitored by TLC to full 
consumption of the starting material (5 minutes to 4 hours). After warming to room 
temperature, water (40 mL) was added, and the products were extracted with ethyl 
acetate (3 × 20 mL). The combined organic extract was washed with brine (40 mL), 
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dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure 
to give crude product as dark brown oil. This was used directly for the next step 
without further purification. 
 
A 100-mL round-bottomed flask equipped with a magnetic stirring bar, a 
stopper and a nitrogen inlet was charged with the dark brown oil in CH2Cl2 (60 mL), 
and the mixture was cooled to 0 °C in an ice-water bath. Pyridinium chlorochromate 
(0.230 g, 1.1 mmol) was slowly added during 2 min via spatula. The mixture was then 
stirred at room temperature and monitored by TLC until completion. The reaction 
mixture was carefully filtered through a pad of Celite and the combined organic 
extracts were successively concentrated. The residue was purified by column 
chromatography on silica gel to give 94 mg (42% over two steps) of the desired product 
5.5b as a yellow oil.  
 
 
 Compound 5.5b has been previously fully characterized.14  
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Benzyl Deprotection of Benzocyclobutenones 
 
 
 
 
A flame-dried, 50 mL Schlenk flask equipped with a magnetic stirring bar, a 
hydrogen gas balloon and a rubber septum was charged with a 5:1 v/v solution of 
glacial acetic acid (10 mL) and 6 M HCl (2 mL) and substrate 5.1b. Pd(OH)2 (50 
mol%) was added to the reaction mixture in one portion and the reaction mixture was 
further stirred for 4 hours at room temperature until completion by TLC. The mixture 
was opened to the air, filtered through a pad of Celite and concentrated under reduced 
pressure to give crude product as dark brown oil. The residue was purified by column 
chromatography on silica gel to give 85% of the desired product as a tan solid.  
 
 
This compound has been previously fully characterized.14  
 
 
 
 
 
 
 
  
74 
 
 
 
 
 
 
 
 
  
75 
 
 
 
 
 
 
  
76 
 
 
 
 
 
 
  
77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
78 
 
 
 
7
8
3
.0
4
9
4
9
.5
8
1
0
4
9
.5
0
1
1
2
9
.9
9
1
2
6
6
.0
0
1
4
7
6
.9
5
1
5
7
1
.3
2
1
5
9
9
.0
7
1
7
6
0
.0
6
2
2
2
3
.5
9
2
3
3
1
.8
4
2
3
5
9
.6
0
2
8
4
2
.5
6
2
9
2
0
.2
8
3
0
3
6
.8
5
3
5
2
2
.5
9
 68
 70
 72
 74
 76
 78
 80
 82
 84
 86
 88
 90
 92
 94
 96
 98
 100
 102
 104
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
79 
 
 
 
7
8
3
.6
4
1
0
4
7
.1
5
1
2
6
8
.0
3
1
4
6
9
.5
4
1
5
6
2
.5
4
1
5
8
9
.6
71
6
0
1
.2
9
1
7
4
8
.5
5
1
7
6
0
.1
7
2
8
5
2
.9
6
2
9
2
6
.5
9
2
9
6
5
.3
4
3
0
7
7
.7
2
 60
 65
 70
 75
 80
 85
 90
 95
 100
 105
 110
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
80 
 
 
 
4
2
0
.8
4
6
4
1
.2
2
7
8
4
.2
6
9
0
3
.7
2
9
7
8
.0
2
1
0
5
0
.2
0
1
1
2
9
.8
2
1
1
5
9
.4
6
1
2
6
9
.5
4
1
3
8
2
.3
5
1
4
4
6
.6
1
1
4
7
4
.1
0
1
5
7
5
.0
4
1
6
0
2
.2
61
7
6
4
.6
8
2
9
2
2
.0
5
 60
 65
 70
 75
 80
 85
 90
 95
 100
 105
 110
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
81 
 
 
 
8
8
8
.2
7
9
6
1
.8
9
1
1
3
2
.4
0
1
2
8
3
.5
3
1
3
3
7
.7
8
1
4
5
7
.9
1
1
5
7
0
.2
9
1
6
1
6
.7
9
1
7
5
6
.3
0
1
8
0
6
.6
7
2
1
8
6
.4
4
2
9
2
2
.7
1
3
0
8
1
.5
9
 60
 65
 70
 75
 80
 85
 90
 95
 100
 105
 110
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
82 
 
 
 
 
 
1
0
4
6
.7
2
1
2
7
4
.3
3
1
4
7
4
.1
7
1
5
7
1
.3
2
1
6
0
1
.8
5
1
7
6
5
.6
1
2
8
5
3
.6
6
2
9
2
3
.0
52
9
7
8
.5
7
 78
 80
 82
 84
 86
 88
 90
 92
 94
 96
 98
 100
 102
 104
 106
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
83 
 
 
 
 
7
9
5
.1
8
9
6
9
.0
1
1
1
2
4
.4
4
1
2
7
0
.1
91
4
7
2
.8
7
1
5
7
1
.3
4
1
6
0
3
.0
4
1
7
5
6
.5
9
1
7
5
7
.2
9
2
3
3
4
.6
2
2
3
6
5
.1
5
2
8
6
7
.5
4
2
9
2
5
.8
3
2
9
6
1
.9
1
3
0
8
4
.0
4
 68
 70
 72
 74
 76
 78
 80
 82
 84
 86
 88
 90
 92
 94
 96
 98
 100
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
84 
 
 
7
7
4
.7
1
9
9
6
.7
6
1
0
8
0
.0
3
1
1
3
5
.5
4
1
2
2
9
.9
2
1
2
8
5
.4
3
1
3
7
4
.2
5
1
4
3
5
.3
1
1
5
7
1
.3
2
1
6
0
4
.6
3
1
7
2
1
.2
0
1
7
6
5
.6
1
2
8
5
3
.6
6
2
9
2
0
.2
8
2
9
5
0
.8
13
0
8
1
.2
6
 97
 98
 99
 100
 101
 102
 103
 104
 105
 106
 107
 108
 109
 110
 111
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
85 
 
 
 
 
1
2
6
4
.1
61
4
5
7
.9
1
1
5
9
3
.5
4
1
7
5
2
.4
2
2
3
2
5
.9
4
2
3
5
6
.9
42
8
4
9
.0
8
2
9
1
8
.8
43
0
5
0
.5
9
 48
 50
 52
 54
 56
 58
 60
 62
 64
 66
 68
 70
 72
 74
 76
 78
 80
 82
 84
 86
 88
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
86 
 
 
 
 
 
  
87 
 
 
 
1
4
6
5
.8
4
1
6
0
7
.4
0
1
6
2
6
.8
3
1
7
1
5
.6
5
2
8
4
2
.5
6
2
9
2
0
.2
8
2
9
4
5
.2
6
3
0
4
7
.9
6
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
 100
%
T
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)
  
88 
 
 
 
 
 
 
 
  
89 
 
 
 
 
  
90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
91 
References 
1. Gutekunst, W.R.; Baran, P.S. C–H Functionalization Logic in Total Synthesis, Chem. 
Soc. Rev. 2011, 40, 1976-1991. 
2. Breitmaier, E. Terpenes: flavors, fragrances, pharmaca, pheromones, WILEY-VCH, 
Weinheim, Germany: 2006. 
3. Modern Alkaloids: Structure, Isolation, Synthesis and Biology By: Fattorusso, Ernesto; 
Taglialatela-Scafati, Orazio; Editors Wiley-VCH Verlag GmbH & Co. KGaA Weinheim, 
Germany, 2008. 
4. Wender, P. A.; Ihle, N. C.; Correia, C. R. D. J. Am. Chem. Soc., 1988, 110, 5904-5906. 
5. Wender, P. A.; Takahashi, H.; Witulski, B. J. Am. Chem. Soc., 1995, 117, 4720–4721. 
6. Jiao, L.; Ye, S.; Yu, Z. J. Am. Chem. Soc., 2008, 130, 7178-7179. 
7. South, M. S.; Liebeskind, L. S. J. Am. Chem. Soc. 1984, 106, 4181. 
8. M. Murakami, T. Itahashi, Y. Ito, J. Am. Chem. Soc. 2002, 124, 13976. 
 
9. Shigeno, M.; Yamamoto, T.; Murakami, M. Chem. Eur. J. 2009, 15, 12929. 
 
10. Nishimura, T.; Matsumura, S.; Maeda, Y.; Uemura, S. Tetrahedron Lett. 2002, 43, 
3037. 
11. Trost, B. M.; Yasukata, T. J. Am. Chem. Soc. 2001, 123, 7162. 
 
12. Seiser, T.; Roth, O. A.; Cramer, N. Angew. Chem., Int. Ed. 2009, 48, 6320. 
 
13. Liu, L.; Ishida, N.; Murakami, M. Angew. Chem., Int. Ed. 2012, 51, 2485. 
14. Xu, T.; Dong, G. Angew. Chem., Int. Ed. 2012, 51, 7567. 
15. Rylander, P. N. in Catalytic Hydrogenation in Organic Synthesis, Academic Press, 
New York, 1979, p.175. 
16. Griffith, W. P.; Ley, S. V.; Whitcombe, G. P.; White, A. D. J. Soc. Chem., Chem. 
Commun. 1987, 1625. 
  
92 
17. Vakalopoulos, A.; Schmeck, C.; Thutewohl, M.; Li, V.; Bischoff, H.; Lustig, K.; 
Weber, O.; Paulsen, H.; Elias, H., Bioorg. Med. Chem. Lett. 2011, 21, 488. 
18. See ref (14). 
19. a) Barile, F.; Bassetti, M.; D’Annibale, A.; Gerometta, R.; Palazzi, M., Eur. J. Org. 
Chem. 2011, 6519. b) Hollingworth, C.; Hazari, A.; Hopkinson, M. N.; Tredwell, M.; 
Benedetto, E.; Huiban, M.; Gee, A. D.; Brown, J. M.; Gouverneur, V., Angew. Chem. Int. 
Ed. 2011, 50, 2613. c) Duan, Z-C.; Hu, X-P.; Zhang, C.; Wang, D-Y.; Yu, S-B.; Zheng, 
C. J. Org. Chem. 2009, 74, 9191. 
20. Sawyer, James R. Rhodium-catalyzed Carbocyclization Reactions for the Synthesis of 
Five- and Six-membered Rings. WorldCat, Bloomington, IN: 2008. 
21. The difference in stability between allenes and dienes is roughly 15 kcal/mol. 
22. Lu, B.; Jiang, X.; Fu, C.; Ma, S. “An Efficient Synthesis of Terminal Allenes from 
Terminal 1-Alkynes” J. Org. Chem,. 2009, 74, 1763-1765. 
23. Duan, Z.; Hu, X.; Zhang, C.; Wang, D.; Yu, S.; Zheng, Z. “Highly Enantioselective 
Rh-Catalyzed Hydrogenation of β,γ-Unsaturated Phosphonates with Chiral Ferrocene-
Based Monophosphoramidite Ligands” J. Org. Chem., 2009, 74, 9191-9194. 
24. Xu, D.; Lu, Z.; Li, Z.; Ma, S. “Novozym 435-Catalyzed Kinetic Resolution of β -
allenols. A Facile Route for the Preparation of Optically Active β –allenols or allenyl 
acetates” Tetrahedron, 2004, 60, 11879-11887. 
25. Sparrow, K.; Barker, D.; Brimble, M. A. “The Enantioselective Synthesis of 
Tetracyclic Methyllycaconitine Analogues” Tetrahedron, 2011, 67, 7989-7999. 
  
93 
26. Xiao, Y.; Liu, P. “IspH Protein of the Deoxyxylulose Phosphate Pathway: 
Mechanistic Studies With C1-Deuterium-Labeled Substrate and Fluorinated Analogue” 
Angew. Chem. 2008, 47, 9722-9725.  
27. Horne, D. B.; Koradin, C.; Shen, H. C.; Steinmetz, B. G.; Toste, F. D.; Trost, B. 
M.  Chemistry - A European Journal, 2005, 11, 8, 2577 – 2590. 
28. Georglou, T.; Montagnon, T.; Pavlakos, E.; Tofi, M.; Vassilikogiannakis, G. Organic 
Letters, 2009, 11, 20, 4556 – 4559. 
29. Ishii, Y.; Gao, C.; Xu, W. X.; Iwasaki, M.; Hidai, M. Journal of Organic 
Chemistry, 1993, 58, 24, 6818 – 6825. 
30. Braverman, S.; Gottlieb, H. E.; Pechenick-Azizi, T.; Sprecher, M. 
Synthesis, 2011, 11, 1741 – 1750. 
31. A. Dermenci, G. Dong, Sci. China Chem. 2013, 56, 685. 
 
32. Liu, L.; Ishida, N.; Murakami, M. Angew. Chem., Int. Ed. 2012, 51, 2485. 
33. K. Teruyuki, N. Ayoko, O. Takumi, S. Nobuyoshi, W. Kenji, M. Take-aki, J. Am. 
Chem. Soc. 2000,  22, 6319. 
34. S. Kotha, A. C. Deb, K. Lahiri, E. Manivannan, Synthesis 2009, 165 and references 
therein. 
35. E. M. Ferreira, B. M. Stoltz, J. Am. Chem. Soc. 2003, 125, 9578. 
36. X.-Z. Shu, S. Huang, D. Shu, I. A. Guzei, W. Tang, Angew. Chem. Int. Ed. 2011, 50, 
8153. 
37. Hartwig, J. F., in Organotransition Metal Chemistry: from Bonding to Catalysis, 
University Science Books Mill Valley. 
38. D. Krois, E. Langer, H. Lehner, Tetrahedron 1980, 36, 1345. 
39. See ref (14). 
40. Jewett, J. C.; Rawal, V. H. Angew. Chem. Int. Ed. 2007, 46, 6502. 
  
94 
41. Kim, D. D.; Lee, S. J.; Beak, P. J. Org. Chem. 2005, 70, 5376. 
42. Falciola, C. A.; Tissot-Croset, K.; Reyneri, H.; Alexakis, A. Adv. Catal. Synth. 2008, 
350, 1090. 
43. Kithching, W.; Henzel, K. A.; Paquette, L. A. J. Am. Chem. Soc. 1975, 97, 4643. 
44. Hodgson, D. M.; Fleming, M. J.; Stanway, S. J. J. Org. Chem. 2007, 72, 4763. 
45. Qiu, W.-W.; Surendra, K.; Yin, L.; Corey, E. J. Org. Lett. 2011, 13, 5893. 
46. Verendel, J. J.; Zhou, T.; Li, J.-Q.; Paptchikhine, A.; Lebedev, O.; Andersson, P. G. 
J. Am. Chem. Soc. 2010, 132, 8880. 
47. Das, J.; Chandrasekaran, S. Tetrahedron 1994, 50, 11709. 
48. Xu, J.; Fu, X.; Low, R.; Goh, Y.-P.; Jiang, Z.; Tan, C.-H. Chem. Commun. 2008, 
5526. 
49. Falciola, C. A.; Tissot-Croset, K.; Reyneri, H.; Alexakis, A. Adv. Catal. Synth. 2008, 
350, 1090. 
50. Whittaker, A. M.; Rucker, R. P.; Lalic, G. Org. Lett. 2010, 12, 3216. 
51. Kraus, G. A.; Wu, T. Tetrahedron 2010, 66, 569. 
 
 
 
 
